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ABSTRACT
 Non-alcoholic fatty liver disease (NAFLD) is an emerging worldwide pandemic 
which is highly prevalent among obese individuals including children and adults. In a 
NAFLD condition, exposure to environmental contaminants or toxins can act as a second 
/ multiple hit, which leads to the progression of simple steatosis to NASH and ultimately 
may result in liver cirrhosis. With climate change today, elevated levels of microcystins 
are an emerging problem in fresh water bodies, which are a source of drinking water. 
Individuals are therefore at risk of exposure to microcystin through consuming 
contaminated water. In the progression of NAFLD from one clinical stage to 
another, microcystin can play an important role. Research has proved that the main 
mechanism of the Microcystin-LR is to work as an exogenous Protein phosphatase 2A 
(PP2A) inhibitor. In this thesis we test the hypothesis that microcystin activates Kupffer 
cells as well as the hepatic stellate cells, which are the crucial mediators in hepatic 
inflammation and fibrogenesis via NOX2 dependent pathway in NAFLD condition. 
Results showed that microcystin exposure via intraperitoneal routes in mice that have mild 
steatosis will lead to advanced histopathological characteristics of NAFLD. Further, we 
looked at the effect of early microcystin exposure in young mice, which were then fed a 
high fat diet to induce obesity/NAFLD. Early exposure to microcystin resulted in 
exacerbation of NAFLD clinical pathology with increased expression of proinflammatory 
cytokines, compared to vehicle control treated mice. This process has been shown to be 
reduced in mice that lacked miR21, p47 phox , or NLRP3 genes. In addition, inhibition of 
vi 
AKT pathway reduced microcystin -induced NOX2 activation  as well as upregulation of 
miR21. All things considered, it was observed that microcystin exposure exacerbated 
NAFLD pathology via activating NOX2-dpendent peroxynitare generation by increasing 
miR21 levels. Moreover, early childhood exposure to microcystin will exacerbate adult 
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Nonalcoholic fatty liver disease (NAFLD) is a pathological condition mostly 
similar to histological features of alcoholic liver disease , but occurs without excessive 
consumption of alcohol [1, 2]. It includes a wide spectrum of liver stages based on 
different histological features ranging from simple steatosis to a complex stage of 
nonalcoholic steatohepatitis (NASH), which may progress to hepatic cirrhosis and 
hepatocellular carcinoma if it remains untreated. The main issue of the first two liver 
stages is that most patients are completely fine and asymptomatic at the beginning until 
they reach irreversible end-stage liver disease [3-5]. This silent liver disease has recently 
become an imperative public health concern because of its high prevalence among both 
adults as well as in juveniles, its high risk of progression to advanced severe liver illnesses 
if neglected, and its strong association with an environmental contaminant [6, 7]. Our group 
as well as other research studies have shown that environmental exposure to contaminants 
as well as toxicants  and/or potentially their metabolites work as a “second and/or multiple 
hit”  in order to exacerbate the pathophysiology of NAFLD [6, 8]. The ‘first hit’ includes 
metabolic changes in body system that involve leptin resistance and/or insulin resistance, 
which in turn result in fat accumulation in the liver (liver steatosis). The first hit can be 
synergized if obesity was there as it causes increase in the level of leptin. The ‘second hit’ 
generally involves pathological state of imbalance that includes a condition such as 
oxidative stress resulting in Kupffer cells activation, as well as Stellate cells activation. 
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These cells activation subsequently result in proinflammatory response and fibrogenesis 
[9-12].   
Nonalcoholic fatty liver disease (NAFLD) is a clinical condition that is related to 
the rising levels of obesity and metabolic disorders [13].NAFLD are most predominant in 
adult obese individuals with high prevalence among them which is around 80-90%. 
Patients with metabolic disorders such as diabetes mellitus have prevalence of 30-50%. 
This percentage will get increased up to 90%  if it is synergized with a condition like 
hyperlipidemia. In pediatrics epidemiology, a NAFLD condition is challenging as that 
children have prevalence of  3-10%. However, this percentage can get a dramatic increase 
to reach 70 % among obese children [14]. 
Obesity is a condition that is associated with different factors that promote a liver 
steatosis stage. For example, liver steatosis happens because of  exaggerated consumption 
of a high fat diet and the other metabolic factors and syndromes such as  NAFLD that is 
associated with decreased fat export in very low density lipoprotein( VLDL), increased de 
novo lipogenesis process, as well as decreased free fatty acid β-oxidation [10]. We can 
consider obesity as a pathological condition because it is associated with 
elevated concentrations of pro inflammatory factors such as cytokines,  like Tumor 
necrosis factor (TNF-α), Interleukin 1β (IL-1β) ,Interleukin 6 (IL-6), and Monocyte 
chemoattractant protein 1 (MCP1) [15]. Moreover, hormones such as adipokines can work 
as proinflammatory factors in obese individuals. For example, leptin can behave as a 
cytokine in the body system [16]. This hormone is regularly secreted in a pulsatile 
phenomenon by the adipocytes and works physiologically as the satiety hormone [16, 17]. 
It has been already shown by our group that mice groups that were fed with a high fat diet 
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and had been exposed to BDCM had increased leptin concentration [6, 18]. Moreover, mice 
that had leptin KO gene  associated with leptin deficiency showed signs of hyperphagia 
and mice became extremely obese as leptin is required after eating to control hunger. Also, 
this hormone is known to be positively associated with the body fat content. This is because 
the hormone specifically works to regulate and change long-term food intake as well as 
affecting energy expenditure in whole body systems [19]. 
Data from the Centers for Disease Control indicate that over a third of the entire 
country’s population is obese. Overall, a significant portion of the adult population in the 
nation is affected by obesity, which is a primary risk factor in the development of many 
diseases. According to Ogden et al,it is estimated that 38.3 percent and 34.3 percent of 
women and men respectively are affected by obesity in the country [20] . Obesity as an 
issue tends to follow precepts of age where it progresses in severity. However, for 
particular races, Blacks and Hispanics, obesity is far more prevalent in youth. For instance, 
prevalence of obesity among participants from these races who are between 2 and 20 years 
of age was at about 17 percent. This is a considerable figure given the age in life and lower 
prevalence of risk factors, further indicating the gravity of the situation. With these 
statistics according to Centers for Disease Control and Prevention (CDC, 2010), 12.7 
million children and adolescents are affected. Obesity is the second leading cause of 
preventable death in the United States after tobacco with an average toll of 300,000 
annually. 
Hepatocyte is one of the major elements of the liver parenchyma with multiple liver 
functions; one of its the important functions is to play a role in controlling carbohydrate 
metabolism by maintaining glucose concentrations in a normal range [21], Lipid 
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metabolism and its modulation are also controlled by the hepatocytes [22], etc. On the other 
hand, Kupffer cell, which is a specialized macrophage that resides in the liver, that liver, is 
situated inside the hepatic sinusoids as it shown by many researchers. It  is plays a key role 
in the innate immunity of the liver and is also involved in  different stress situations such 
as infection, toxins, ischemia, resection and other stresses [23] . They are representing 
approximately 80-90% of all tissue macrophages in the body. Stellate cells which is also 
known as Ito cells ,cells, are responsible for liver fibrosis as a response to different stressors 
[24, 25]. All above cells has shown role in advancing NAFLD progression into NASH [6, 
12, 26]. For example according to Lanthier, Kupffer cells activation is considered as key 
element disease initiation and progression from NAFLD to NASH, while stellate cells are 
known to contribute to fibrosis  as well as hepatocytes ballooning  were found to be crucial 
in progression of NAFLD to NASH [27, 28]. 
Regarding how these environmental contaminants cause oxidative stress remains 
unclear. We and others have previously shown that the environmental toxin such as 
trihalomethane, pyrazole exacerbates NAFLD via oxidative stress induced by free radical 
mechanism, thus suggesting that reactive oxidative species and reactive nitrosative species 
play a critical role in the pathogenesis of environmental toxin induced NASH [6, 25, 29] . 
Previous studies have shown that the potential sources of oxidative stress includes xanthine 
oxidase (XDH) [30], electron transport chain enzymes, liver cytochrome P450-2E1 
(CYP2E1) [31], and catalytic subunit of nicotinamide adenine dinucleotide phosphate-
oxidase (NADPH oxidase or NOX) [32]. NADPH oxidase is a membrane bound 
oxidoreductase enzyme complex with a membranous subunit and cytoplasmic subunit. The 
dormant NOX complex is activated to assemble in the membrane and produce superoxide 
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radicals in a respiratory burst or environmental toxin [33]. Both the expression and activity 
of the NOX2 (NOX isoforms) is increased in the NAFLD liver and, importantly, increased 
expression correlates well with NAFLD severity [34]. 
The proliferation and expansion of harmful algal blooms (HABs) or toxic 
cyanobacterial blooms are an important consequence of climate change [35]. These HAB 
contain cyanobacteria which produce toxic metabolites and these often end up in drinking 
water for humans and livestock [36]. According to WHO  guidelines, the amount of  MC-
LR in drinking water should not exceed1µg/L [37]. However, MC-LR was found to occur 
in very high concentrations in several water bodies, which are a source of drinking water 
to both livestock and human [38]. For instance, Poyang Lake (largest fresh water lake in 
China) and Hoan Kiem Lake of northern Vietnam recorded 7.97 µg/L and 46 µg/L 
respectively [38]. There are different routes for exposure to the microcystin; drinking water 
is considered the most common route. There are other routes such as ingestion of 
contaminated food, by inhalation and dermal contact during bathing or showering, and 
during recreational activities [39, 40]. Inhalation exposure also has been reported as 
another route for microcystin exposure [41]. 
Among other cyanotoxins (saxitoxin, anatoxin, cylindrospermopsin),  microcystin 
have been the most studied cyanotoxin so far [37]. Microcystin-LR is known to be a potent 
toxin that can cause damage to  different organs and body systems [42]. The liver is 
considered to be an important target because of its toxicity and because it is known to be a 
potent hepatotoxin. Regarding its chemistry, it has a heptapeptide structure and has a 
molecular weight that varies between 900 and 1,100 Daltons. Based on the changes on 
amino acid position, it will have different Congener within X and Y direction. Microcystin-
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LR, which has leucine (L) and arginine (R) in the X and Y, is considered the most important 
one because it’s potent toxicity and most encountered variant Congener with different 
exposure routes among the microcystin family [43]. 
More than one species of cyanobacteria can synthesize the cyanotoxin [43]. 
Microcystin is an example of cyanotoxins produced by cyanobacteria Microcystis 
aeruginosa in HAB [44]. Microcystin as well as other toxins remain preserved inside the 
cyanobacteria cell structure until unusual conditions happen that favor cell wall lysis. So, 
the cyanotoxin  gets out of the cyanobacteria, called blue-green algae, contaminating the 
fresh water as it is predominant in eutrophic (nutrient-rich) water bodies [45]. 
(WHO) set a guideline for MC-LR in drinking water which is 1µg/L [37]. However, 
MC-LR was found to be more than the recommended guideline in many water bodies [38]. 
For instance, Poyang Lake (largest fresh water lake in China) and Hoan Kiem Lake of 
northern Vietnam recorded 7.97 µg/L and 46 µg/L respectively [38]. 
MC-LR is chemically stable, resistant to gastro-intestinal digestion and transported 
to the liver via active transport system. In addition, it shows toxic effects to liver cells. 
Microcystin needs a facilitated transport system in order to get inside the cell using 
receptors which is the organic acid transporter polypeptide (OATp) family [46-48]. This is 
because microcystin has molecular weight that is very high, preventing it from passing to 
the cells via simple diffusion [49].  
Microcystin-LR down regulates with serine/ threonine protein phosphatases 
(protein phosphatases) such as Protein phosphatase 2A (PP2A) after cell being exposed to 
microcystin [50]. Most of the mechanistic actions regarding microcystin effect have been 
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shown by hyperphosphorylation of the proteins by decreased dephosphorylation process 
by a phosphatase enzyme as it is known to be a potent inhibitor of PP2A [51]. 
Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) has 
different isoforms such as NOX1-5 and Doux1-2. NOX2, which is one of the isoforms and 
can be considered as an important cellular source for reactive oxygen species(ROS) [52]. 
NOX2 has been proven to be expressed in the hepatocyte as well as has been proven in 
several studies that its expression in different cell types such as smooth muscle cells, 
Kupffer cells and hepatic stellate cells [53-55]. NOX2, in order to be activated, has six 
different subunits and it needs two subunits of the six, (α subunit, and  β subunit) depending 
on tissue or cell type, to interact together in order to form an active enzyme complex [55]. 
Then, when it is activated, it will result in generating superoxide anion and reactive oxygen 
species (ROS) [56]. For example, during activation of Kupffer cells, P47 Phox subunit will 
be translocated to the cell membranes to bind GP91 Phox subunit. We have shown this 
activation via translocation by showing significant increase in the protein colocalization 
events by using dual staining using immunofluorescence microscopy [55, 57]. 
MicroRNAs (miRs) are very small noncoding RNAs that control both mRNA and 
target gene protein expression, leading to changes in mRNA stability or inhibition of 
translation depending on MicroRNA itself. For example, MicroRNAs are about 22 
nucleotides, that is the reason for considering them small noncoding RNAs . One aspect 
related to them is that miRNAs form mRNA silencing complexes in cytoplasm that can 
regulate as well as control mRNA expression at transcription stage [58]. Downregulation 
or upregulation of miRNAs can determine the pathway of the cellular mechanism. For 
example, activation of leptin-mediated NADPH oxidase was positively associated with 
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higher levels of miR21 expression in NASH condition. MicroRNA 21 among all miRNAs, 
has been discovered as an important player in NASH pathophysiology [59, 60]. 
In this dissertation, I inspect cues in mechanism pathways of microcystin exposure 
in liver in Non-alcoholic fatty liver disease (NAFLD) causing Nonalcoholic steatohepatitis 
(NASH) and liver injury. One of these mechanisms is that microcystins can exacerbates 
NAFLD pathophysiology via generation of peroxynitrite that is NOX2-dependent , via 
increasing pathology caused by miR21. Moreover, early exposure to microcystins 
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Abstract: 
Nonalcoholic fatty liver disease (NAFLD) is an emerging global pandemic. Though 
significant progress has been made in unraveling the pathophysiology of the disease, the 
role of protein phosphatase 2A (PP2A) and its subsequent inhibition by environmental and 
genetic factors in NAFLD pathophysiology remains unclear. The present report tests the 
hypothesis that an exogenous PP2A inhibitor leads to hepatic inflammation and 
fibrogenesis via an NADPH oxidase 2 (NOX2)-dependent pathway in NAFLD. Results 
showed that microcystin (MC) administration, a potent PP2A inhibitor found in 
environmental exposure, led to an exacerbation of NAFLD pathology with increased CD68 
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immunoreactivity, the release of proinflammatory cytokines, and stellate cell activation, a 
process that was attenuated in mice that lacked the p47phox gene and miR21 knockout 
mice. Mechanistically, leptin-primed immortalized Kupffer cells (a mimicked model for 
an NAFLD condition) treated with apocynin or nitrone spin trap 5,5 dimethyl-1- pyrroline 
N-oxide (DMPO) had significantly decreased CD68 and decreased miR21 and α-smooth 
muscle actin levels, suggesting the role of NOX2-dependent reactive oxygen species in 
miR21-induced Kupffer cell activation and stellate cell pathology. Furthermore, NOX2-
dependent peroxynitrite generation was primarily responsible for cellular events observed 
following MC exposure since incubation with phenylboronic acid attenuated miR21 levels, 
Kupffer cell activation, and inflammatory cytokine release. Furthermore, blocking of the 
AKT pathway attenuated PP2A inhibitor-induced NOX2 activation and miR21 
upregulation. Taken together, we show that PP2A may have protective roles, and its 
inhibition exacerbates NAFLD pathology via activating NOX2-dependent peroxynitrite 
generation, thus increasing miR21-induced pathology. NEW & NOTEWORTHY Protein 
phosphatase 2A inhibition causes nonalcoholic steatohepatitis (NASH) progression via 
NADPH oxidase 2. In addition to a novel mechanism of action, we describe a new tool to 
describe NASH histopathology. 
2.1 INTRODUCTION 
Nonalcoholic Fatty liver disease (NAFLD), a silent liver disease, has recently 
become an imperative public health concern because of its high prevalence, high risk of 
progression to severe liver illnesses, and strong association with environmental and genetic 
factors [6, 61]. Nonalcoholic steatohepatitis (NASH) progression is believed to be 
governed by a multihit paradigm. Earlier studies have shown that oxidative stress resulting 
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from exposure to environmental contaminants and/or their metabolites act as a “second hit” 
or “multiple hits” to exacerbate NAFLD to NASH pathophysiology [6, 8]. The “first hit” 
includes leptin resistance or insulin resistance, which might stimulate fat accumulation in 
the liver (steatosis). The second hit generally involves oxidative stress and/or cytokines 
that result in Kupffer cell and stellate cell activation, proinflammatory response, and 
fibrogenesis. 
Environmental contaminants have been shown to act as a second hit in NAFLD for 
its progression to NASH and liver fibrosis. Recent incidences of higher cyanobacterial 
blooms that have been shown to release and concomitantly expose individuals to protein 
phosphatase 2A (PP2A) inhibitors like microcystin (MC) can be a significant threat to 
NAFLD patients of all ages. MC exposure through these cyanobacterial blooms can act as 
a second hit or may combine with other underlying factors such as insulin and leptin 
resistance and lipotoxicity, as found in morbid obesity to advance into severe liver disease 
from a primarily benign steatotic condition. MC is an emerging drinking water contaminant 
and imposes global health concern [62]. Preventing MC-induced liver injury is crucial to 
understand the molecular mechanism behind the toxicity of MC [63]. Recent studies 
largely focus on MC-induced oxidative stress, apoptosis, and oncotic necrosis as a cause 
of liver injury [63-66]. MC exposure also has been associated with increased incidences of 
liver cancer [67]. Though the environmental impact of MC remains alarming, it is too early 
to predict that exposures from such PP2A inhibitors might be one of the causes for NAFLD 
progression to NASH. PP2A consists of a large family of Ser/Thr phosphatases, consisting 
of a catalytic C subunit and a structural A subunit that is widely bound to a regulatory B-
type subunit [37]. The B-type subunits determine the function and modulation of PP2A 
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trimers, but despite their importance in physiology, their roles in controlling vital pathology 
processes in the liver remain under investigated [37]. Conditional knockouts (KOs) of this 
gene, specifically in the liver in the C57BL6 background, result in less lipid deposition in 
the liver (decreased steatosis) [68]. The role of steatosis in NAFLD pathology remains an 
area of intense scrutiny. With PP2A inhibition leading to less steatosis, previous studies 
concerning loss of liver fat and its association with inflammation in the liver might provide 
some insight into the role of PP2A in NAFLD, especially if it is inhibited by an 
environmental factor like MC. Earlier studies, including ours, have shown that the potential 
sources of oxidative stress include xanthine oxidase (XDH) [30], electron transport chain 
enzymes, liver cytochrome P450–2E1 (CYP2E1) [31], and catalytic subunit of NADPH 
oxidase (or NOX) [32]. We and others have previously shown that NADPH oxidase 2 
(NOX2)-induced peroxynitrite produces a stable nitrated tyrosine residue on proteins [3-
nitrotyrosine (3NT)] in NAFLD. Indeed, 3NT is being considered as an established 
biomarker of oxidative stress in both an in vitro and an in vivo model of oxidative stress 
[69]. Even though peroxynitrite was discovered decades ago, the mechanism of reactive 
oxygen species (ROS) signaling in progressive NAFLD remains unclear, especially the 
route of its activation by exogenous triggers and its downstream signaling that links 
inflammatory pathways. 
NOX2- mediated redox signaling can activate micro RNAs. Previous studies have 
shown the role of microRNAs (miR21) in disease pathology over the past decade. miRNAs 
are small (18~25 nucleotides long), endogenous, noncoding RNA molecules that regulate 
gene expression at the transcriptional level [70, 71]. Most recently we and several research 
groups have shown that microRNA 21 (miR21) is one of the most upregulated microRNAs 
14 
 
in NAFLD and NAFLD-associated kidney inflammation [57, 72, 73]. miR21 was shown 
to regulate the SMAD pathway in NAFLD fibrogenesis [57]. Since both ROS and miR21 
are dysregulated in progressive NAFLD, it is important to understand the crosstalk between 
the external triggers and upstream and downstream pathways of NOX2-induced miR21 
activation. Justifiably, since numerous studies have shown that NOX2 activation is 
regulated by environmental triggers which act as second hits, mechanistically, we chose to 
investigate whether MC, a toxin produced from cyanobacteria in harmful algal blooms and 
a known PP2A inhibitor [51], activated an NOX2-miR21 signaling pathway and 
exacerbated NASH pathogenesis. 
2.2 MATERIALS AND METHODS 
Materials: 
All other chemicals were of analytical grade and were purchased from Sigma 
Chemical Company unless otherwise specified. MC-LR was purchased from Cayman (Ann 
Arbor, MI); leptin was purchased from BioVision (Milpitas, CA); LB-100, the PP2A 
inhibitor, was purchased from MedKoo; and wild-type and gene-specific KO mice, 
including P47 phox KO and miR21 KO mice, were purchased from Jackson Laboratories 
(Bar Harbor, ME). Animal diets were purchased from Research Diets (New Brunswick, 
NJ). Anti-3NT, anti-CD68, anti-GP91 phox, anti-P47 phox, and anti-α-smooth muscle 
actin (SMA) primary antibodies were purchased from Abcam (Cambridge, MA). Anti-
P65 and anti-p-AKT were purchased from Santa Cruz Biotechnology (Dallas, TX). 
Species-specific biotinylated-conjugated secondary antibody and streptavidin-horseradish 
peroxidase were purchased from Vector Laboratories (Vectastain Elite ABC kit, 
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Burlingame, CA). Fluorescence-conjugated (Alexa Fluor) secondary antibodies and 
ProLong Gold antifade mounting media with DAPI were bought from Thermo Fisher 
Scientific (Waltham, MA). 
Mouse Model: 
Diet-induced NAFLD model: 
Pathogen-free adult male mice with C57BL/6J background (Jackson Laboratories) 
were used in the study. They were fed with a high-fat (60% kcal) supplemented 
methionine-choline-deficient (MCD-HFD) diet, (Research Diets) for 8 wk to induce 
NAFLD, whereas mice kept on a normal chow diet were used as a lean control. Mice that 
contained the disrupted P47 phox gene (B6(cg)-Ncf1M1J/J(JAC004742) and disrupted 
miR21 gene (B6.129S6-Mir21tm1 Yoli/J) (Jackson Laboratories) were also fed an MCD-
HFD and were treated identically to the NAFLD mouse model. All mice were housed with 
3–5 mice/cage at 23°C–24°C on a 12:12-h light-dark cycle with ad libitum access to food 
and water. All animals were treated in strict accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals, and the experiments were 
approved by the institutional review board at the University of South Carolina at Columbia. 
Induction of liver injury and exposure to environmental toxin MC: 
Wild-type, as well as gene-specific KO mice, at 6 wk were administered with 
vehicle (ethanol in PBS), MC-LR (MC-LR) (10 µg/kg, 5 dosages/wk), through the 
intraperitoneal route for 2 wk. A set of MCD-HFD-fed mice (NAFLD model) was not 
injected with MC-LR in this study. On completion of treatment, mice were euthanized, and 
serum or liver tissue was collected for further processing. 
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Kupffer Cell Culture and Treatments: 
Immortalized rat Kupffer cell line (SV40) was grown and maintained in complete 
DMEM. The media was supplemented with 10% FBS (Atlanta Biologicals; Norcross, GA), 
2 mM glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin (Gibco; Grand Island, 
NY) at 37°C in a humidified atmosphere of 5% CO2. Cells were serum starved (DMEM 
with 1% FBS) overnight before cells were given any treatment. The cells were then treated 
with vehicle (control) or 100 ng/mL leptin (BioVision), MC-LR (20 μM), or PP2A 
inhibitor (5 µM). Other groups of cells were incubated with leptin, MC, or PP2A inhibitor 
in combination with 100 μM apocynin (Apo) (Sigma-Aldrich), an inhibitor of NADPH 
oxidase activity, and thus preventing production of superoxide, 100 μM phenyl boronic 
acid (FBA), was used as a scavenger for 100 mM peroxynitrite, the spin trap DMPO 
(Alexis Biochemical, San Diego, CA), 20 µM miR21 inhibitor (Qiagen; Valencia, CA), 
and AKTi [50 µM phosphatidylinositol 3-kinase inhibitor (LY294002) (AKTi)]. The cells 
were then lysed in TRIzol (Invitrogen; Grand Island, NY) for mRNA as well miRNA 
extraction or plated on coverslips (MatTek; Ashland, MA) for immunofluorescence 
staining after completion of the treatment. 
Stellate Cell Culture and Treatments: 
An immortalized rat hepatic stellate cell line (8B), kindly provided to us by Dr. 
Anna Mae Diehl (Duke-Gastroenterology), was maintained in high-glucose DMEM 
(Corning, Tewksbury, MA) supplemented with 10% FBS (Atlanta Biologicals), 2 mM 
glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin (Gibco) at 37°C in a 
humidified atmosphere of 5% CO2. The cells were then treated as Kupffer cells 
(see Kupffer Cell Culture and Treatments). After treatments, the cells were lysed in TRIzol 
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(Invitrogen) for mRNA or plated on coverslips (MatTek Corp) for immunofluorescence 
staining after completion of the treatment. 
Histopathology and Digital Imaging Analysis of NAFLD: 
Sections of liver tissue from each mouse were collected and fixed in 10% neutral 
buffered formalin. These formalin-fixed, paraffin-embedded tissues were cut into 5-μm 
thick sections. For histological examinations, formalin-fixed liver sections were stained 
with hematoxylin-eosin by the Instrumentation Resource Facility, University of South 
Carolina School of Medicine, and observed under the light microscope. For the quantitative 
analysis of NAFLD, liver slices were scanned at ×20 using a NanoZoomer-SQ 
(Hamamatsu Corporation, Hamamatsu, Japan), and digital images of entire liver sections 
were captured at ×20x (pixel size: 0.452 µm) using NDPview 2 software (Hamamatsu, 
Japan). Steatosis, fibrosis, and liver tissue density were automatically assessed from the 
same entire liver sections stained with picrosirius red, using Biocellvia’s image processing 
software program. The liver steatosis was defined by the steatosis area index, which 
corresponds, for a liver section, to the ratio of the total surface of vesicles (diameter >5 
µm) versus the total surface of the liver section, expressed in percent. The liver fibrosis 
was defined, for a liver section, as the ratio of the area of stained collagen fibers versus the 
total area of the liver section, expressed in percent. The liver tissue density was assessed 
automatically from the mean density value of thousands of microtiles overlaying the entire 
liver sections and previously detailed for the pulmonary tissue density [74]. 
Immunohistochemistry: 
The liver sections were deparaffinized using a standard protocol. Briefly, sections 
were incubated with xylene twice for 3 min, washed with xylene-ethanol (1:1) for 3 min, 
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rehydrated through a series of ethanol (twice with 100%, 95%, 70%, and 50%) twice with 
distilled water, and finally rinsed twice with PBS (Sigma-Aldrich). Antigen epitope 
retrieval of the deparaffinized sections was performed using epitope retrieval solution and 
steamer (IHC World, Woodstock, MD) for 45 min. H2O2 (3%) was used for 5 min to block 
the endogenous peroxidases. The primary antibody for CD68 (1:300, ab125212, Abcam), 
α-SMA (1:250, ab32575, Abcam), 3NT (1:250, ab110282, Abcam), P-65 (1:300, SC-8008, 
Santa Cruz Biotechnology), and p-AKT (1:300, SC-293125, Santa Cruz Biotechnology) 
were used overnight in recommended dilutions. Species-specific biotinylated-conjugated 
secondary antibody and streptavidin conjugated with horseradish peroxidase were used to 
perform antigen-specific immunohistochemistry according to the manufacturer’s standard 
protocols. 3,3′ diaminobenzidine (Sigma-Aldrich) was used as a chromogenic substrate. 
Tissue sections were counterstained with Mayer’s hematoxylin (Sigma-Aldrich). 
Phosphate-buffered saline was used for washing three times between the steps. Sections 
were finally mounted in Simpo mount (GBI Laboratories, Mukilteo, WA) and observed 
under a ×20 objective using an Olympus BX51 microscope (Olympus, America). 
Morphometric analysis was done using CellSens Software from Olympus America (Center 
Valley, PA). 
Immunofluorescence Microscopy: 
In vivo, formalin-fixed, paraffin-embedded liver tissue sections were subjected to 
deparaffinization according to standard instructions. Epitope retrieval of the deparaffinized 
sections was done with an epitope retrieval solution and steamer (IHC World) according 
to the manufacturer's protocol. The primary antibodies anti-GP-91 phox (SC-5827) and 
anti-p47 phox (SC-17845) were used at recommended dilutions at 1:300. Species-specific 
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anti-IgG secondary antibodies conjugated with Alexa Fluor 633 or 488 (Invitrogen) were 
used. The sections were mounted in a ProLong Gold antifade reagent with DAPI (Life 
Technologies, Carlsbad, CA). Images were taken under ×20, ×40, and ×60 magnification 
with an Olympus BX51 microscope. 
In vitro, after completion of the treatments under serum-starved conditions as in 
cell culture, cells attached on coverslips were fixed with 10% neutral buffered saline. After 
the cells were washed with PBS containing 0.1% Triton X (Sigma), they were blocked with 
3% BSA, 0.2% Tween (Fisher), and 10% FBS in PBS. Cells were incubated with primary 
antibodies, anti- α-SMA (ab32575) and anti-3NT (ab110282) (Abcam), and were used at 
1:250 dilution, followed by species-specific secondary antibody conjugated with Alexa 
Fluor 633 or 488. The stained cells attached on the coverslips were mounted on slides with 
ProLong Gold antifade reagent with DAPI (Life Technologies) and viewed under ×40 and 
×60 magnification with an Olympus BX51 microscope. 
Serum Alanine Aminotransferase: 
Serum alanine aminotransferase (ALT) levels were quantified using an automated 
analyzer at the University of Georgia Clinical pathology core facility. 
Quantitative Real-Time Polymerase Chain Reaction: 
Gene expression (mRNA and miRNA) levels from mice liver tissue and the 
immortalized rat hepatic stellate cell line (8B) were measured by quantitative real-time 
reverse transcription-polymerase chain reaction (qRT-PCR) by following our routine 
laboratory protocol. The primers used for RT-PCR in 5′ to 3′ orientations are provided 





Table 2.1. Primer sequences for the different target genes. 




















































Western Blot Analysis: 
Each liver protein lysate (25 μg each) was resolved on 4%–12% bis-Tris gradient 
gel (Invitrogen). Resolved protein bands were transferred (semidry) to nitrocellulose 
membrane using the Trans-Blot Turbo transfer system (Bio-Rad Laboratories, Hercules, 
CA). Primary antibodies P65 (SC-8008, Santa Cruz Biotechnology), AKT and p-AKT 
(9272 and 4060, respectively, Cell Signaling Technology), and PP2A (ab32065, Abcam) 
were used at recommended dilutions (1:500), as well as β-actin used at 1:1,000, and 
compatible horseradish peroxidase-conjugated species-specific secondary antibodies were 
used at 1:5,000 dilutions. Pierce ECL Western Blotting Substrate (Thermo Fisher 
Scientific, Rockford, IL) was used for detection. The blot was imaged using G:BoxChemi 
XX6 (Syngene Imaging Systems) and subjected to densitometry analysis using Image J. 
Estimation of Nitric Oxide: 
Nitric oxide (NO) was estimated by measuring total nitrite formation in freshly 
harvested cell culture fluids using the Griess Reagent system (Promega, Madison, WI) 






All in vivo experiments were repeated three times with at least 3 mice per group 
(n = 3; data from each group of 3 mice were pooled). All in vitro experiments were repeated 
at least 3 times (n = 3). The statistical analysis was carried out by unpaired t-test and 
ANOVA. For all analyses, P < 0.05 was considered statistically significant. 
2.3 RESULTS 
Exogenous PP2A inhibitor exacerbates NAFLD pathology 
 We and others have shown that environmental contaminants and their metabolites 
act as a second hit to exacerbate NAFLD pathophysiology [6, 8]. To study the role of MC-
LR, an exogenous PP2A inhibitor in exacerbating NASH, we used MCD-HFD-fed mice to 
induce NAFLD, followed by a low, chronic dose of MC (NAFLD + MC). The NAFLD + 
MC mice showed a marked increase in NASH pathophysiology, as shown by increased 
infiltrating immune cells (inflammation), hepatocytes with bipolar nuclei, and ballooning 
when compared with NAFLD control mice alone or lean mice exposed to MC (lean + MC) 
(Fig.2.1 A). Liver tissues were analyzed next for steatosis and fibrosis status by picrosirius 
red staining. NAFLD + MC liver showed significantly increased sinusoidal and bridging 
fibrosis as compared with NAFLD, lean, or lean + MC mice (P < 0.001) (Fig.2.1, B and F). 
NAFLD + MC mice also showed decreased total steatosis area (Fig.2. 1D) and mean 
vesicle size (Fig.2.1E) when compared with NAFLD mice (P < 0.001). However, the tissue 
density of NAFLD + MC mice liver was improved when compared with NAFLD mice 
alone (P < 0.001) (Fig.2.1G). In addition, the NAFLD + MC mice group showed increased 
NASH CRN score with increased lobular inflammation, hepatocyte ballooning, and 
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fibrosis when compared with both NAFLD control mice and lean + MC mice (Table 2.2). 
Serum ALT levels were increased in both lean and NAFLD mice exposed to MC as 
compared with either lean mice or NAFLD control mice, respectively (Fig.2.1C).We 
analyzed the mRNA expression of the two subunits of PP2A, namely PP2AR and PP2AC, 
in the murine liver. We observed that there was a significant increase in the PP2AR and 
PP2AC subunits in the NAFLD + MC group compared with the lean or lean + MC group 
in the mouse liver (*P < 0.05) (Fig.2.1, J and K). A similar significant increase 
in PP2AR and PP2AC was observed in the human NASH liver compared with the human 
control liver (*P < 0.05) (Fig.2.1, N and O). We used Western blot analysis to analyze the 
protein levels of PP2A, and our results showed an increased expression of PP2A in the 
NAFLD and NAFLD + MC (*P < 0.05) groups compared with the lean mouse control 
(Fig.2.1, H and I), though there was a decrease in the PP2A protein expression in the 
NASH group compared with the control group in human (Fig.2. 1, L and M). These results 
clearly showed that the exposure to exogenous PP2A inhibitor was significantly affecting 
the activity rather than the levels in the mouse liver. 








Steatosis 0 0 3 2 
Lobular 
inflammation 
0 1 1 2 
Hepatocyte 
Ballooning 
0 0 1 2 
Stage of fibrosis 0 1A 1C 2 
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Activation of Kupffer cells and hepatic stellate cells in an underlying NAFLD 
condition by exogenous PP2A inhibitor MC. 
Liver inflammation and fibrosis are the two major stages of NASH pathogenesis 
[75]. These two stages are regulated by liver-specific cell types such as resident 
macrophages or Kupffer cells and hepatic stellate cells. To investigate whether MC 
activated both Kupffer cells and hepatic stellate cells, immunoreactivities of Kupffer cell 
activation marker CD68, CD11b, and hepatic stellate cell activation marker α-SMA were 
analyzed in liver slices. Results showed that there was a significant increase in CD68 as 
well as CD11b immunoreactivity in NAFLD + MC mice as compared with NAFLD alone 
or lean + MC groups of mice (P < 0.001) (Fig.2.2, A, C, D, and F). Similarly, α-SMA 
immunoreactivity, a hallmark of stellate cell activation, was significantly increased in 
NAFLD + MC mice groups when compared with NAFLD mice or the lean + MC mice 
group (P < 0.001) (Fig.2.2, B and E). These results were further confirmed at mRNA level. 
CD68 mRNA expression was significantly increased in NAFLD + MC groups when 
compared with NAFLD mice or lean + MC mice alone (P = 0.018 and P = 0.012, 
respectively) (Fig.2.2, I). The above results suggested that in an underlying condition of 
NAFLD, exposure to an exogenous PP2A inhibitor activated Kupffer cells and hepatic 
stellate cells, and the resultant activation of these cell types could generate a 
proinflammatory and fibrotic phenotype. To assess that the Kupffer cell activation 
participated in a proinflammatory phenotype, mRNA expression of proinflammatory 
cytokines such as monocyte-chemoattractant protein-1 (MCP-1, CCL2) and tumor necrosis 
factor-α (TNF-α) were examined. The result showed that there was a significant increase 
in both CCL2 and TNF-αmRNA expression in NAFLD + MC mice when compared with 
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NAFLD and lean + MC mice (P < 0.001) (Fig.2.2, G and H). The above results thus 
suggested that an exogenous PP2A inhibitor exposure in NAFLD induced proinflammatory 
responses via CCL2 and TNF-α. 
Exogenous PP2A inhibitor MC induces NOX2-dependent oxidative stress in NASH 
pathogenesis. 
To study whether MC synergized NOX2 activation in NASH progression, 
immunostaining of both the membrane subunit (GP91 phox) and cytoplasmic subunit (p47 
phox) of NOX2 was performed. Results showed that the colocalization events of both 
subunits were significantly increased in NAFLD + MC mice as compared with NAFLD 
mice or lean + MC mice alone (P = 0.015 and P < 0.001, respectively) (Fig.2. 3, A and C). 
The mRNA expression of p47 phox was significantly increased in NAFLD + MC mice as 
compared with NAFLD mice or lean + MC mice alone (Fig.2.3,D). Interestingly, lean mice 
exposed with MC (lean + MC) showed a significant increase in p47 phox mRNA 
expression as compared with lean mice alone (P < 0.001) (Fig.2.3, D) but did not show 
significant increase in GP91 phox-p47 phox colocalization events (Fig.2.3, A and C). 
There are significant colocalization events for CD68 and GP91 phox subunits in NAFLD 
+ MC mice when compared with the NAFLD group as well as the other groups (Fig.2.3, 
B). CD68 is the marker for the activated Kuppfer cells in the liver, and colocalization 
of GP91 phox with CD68 suggests that NOX2 is activated in the Kuppfer cells. The result 
suggested that MC exacerbated NOX2 activation in an underlying condition of NAFLD. 
Furthermore, to investigate the role NOX2 in peroxynitrite generation and subsequent 
NASH progression, we used P47 phox gene-deleted mice (P47phox KO) fed with an 
MCD-HFD and exposed them to the exogenous PP2A inhibitor. The 
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immunohistochemistry of 3NT, a marker of peroxynitrite-induced oxidative stress, Kupffer 
cell activation marker CD68, CD11b, and stellate cell activation marker (α-SMA) was 
performed. Results showed that there was an increased immunoreactivity of 3NT in 
NAFLD + MC mice when compared with NAFLD mice alone, whereas there was a 
significant decrease in p47 phox KO mice groups exposed with MC (P = 0.013) 
(Fig.2.3, E and I). These results suggested that the peroxynitrite-induced oxidative stress 
as a result of PP2A inhibition exacerbated NASH and was NOX2 dependent. Results also 
showed increased immunoreactivity of CD68, CD11b, and α-SMA in NAFLD + MC mice 
groups as compared with NAFLD alone, whereas there was a significant decrease in P47 
phox KO mice groups (P < 0.001) (Fig.2.3, F–H and J–L). The mRNA expression of 
proinflammatory cytokines CD68, CCl2, and TNF-α showed a significant increase in 
NAFLD + MC mice groups, whereas a decrease in P47 phox KO mice was observed 
(Fig.2.3, M). The data suggested that the exogenous PP2A inhibitor activated Kupffer and 
stellate cells, increased inflammation, and were primarily NOX2 dependent. 
Exogenous PP2A inhibitor MC synergistically increases NOX2 activation and 
tyrosine nitration in Kupffer cells. 
Recent studies have shown that activated NOX2 generates ROS in microglia and 
macrophages in traumatic brain injury [76] and is the primary source of oxidative stress in 
macrophages [77, 78]. To study whether MC generated NOX2-dependent oxidative stress 
via a free radical mechanism in hepatic resident macrophages, leptin-primed Kupffer cells 
(leptin resistance condition of NAFLD) were exposed to MC. Results showed a significant 
increase in GP91 phox-p47 phox colocalization events in leptin + MC-exposed Kupffer 
cells as compared with vehicle control (control) or leptin-primed control cells (leptin) or 
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MC-treated cells (P < 0.001, P = 0.04, and P = 0.018, respectively) (Fig.2.4, A, i–
v and 2.4, B). However, leptin-primed cells treated with Apo (a nonspecific inhibitor of 
NADPH oxidase) and exposed to MC showed a significant decrease in GP91 phox-p47 
phox colocalization events as compared with leptin + MC group cells (P < 0.001) (Fig.2.4, 
A,iv and v, and 2.4, B). Interestingly, leptin-primed Kupffer cells exposed with MC 
showed a significant increase in 3NT immunoreactivity when compared with either vehicle 
control (control), leptin-primed, or MC-treated cells. In addition, leptin-primed cells 
exposed to MC and either Apo, DMPO (free radical spin trap), or FBA (peroxynitrite 
scavenger) showed a significant decrease in 3NT immunoreactivity (Fig.2.5, A and B). 
The above data suggested that in exogenous PP2A inhibitor-induced NASH, Kupffer cells 
might be the major cellular site for NOX2-dependent ROS generation. 
Exogenous PP2A inhibitor-induced NOX2 triggers miR21-dependent NF-κB 
pathway activation in NASH. 
NOX2 plays a significant role in regulating noncoding, small miRNAs. We and 
others have shown previously that NOX2 positively regulates miR21 in renal inflammation 
and lung cancer [72, 79]. To study whether NOX2-mediated oxidative stress triggered by 
a prior expression of an exogenous PP2A inhibitor can activate an miR21 signaling 
pathway in progressive NASH, its expression was analyzed by qRT-PCR in liver tissue. 
Results showed that there was a significant increase in miR21 expression in NAFLD + MC 
mice as compared with NAFLD control mice (P < 0.001) (Fig.2.6, A). However, P47 
phox KO mice exposed with MC showed a significant decrease in miR21 expression in 
liver tissue (P = 0.04) (Fig.2.6, A). The data clearly suggested that miR21 expression was 
NOX2 dependent in MC-triggered NASH pathology. Furthermore, we studied the role of 
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miR21 in NASH pathogenesis. We used miR21 gene-deleted mice (miR21 KO) exposed 
to MC followed by the analysis of Kupffer cell pathology, stellate cell activation, and 
proinflammatory cytokine expression. Results showed a significant increase in 
CD68, CCL2, and TNF-αmRNA expression (P > 0.01) (Fig.2.6, B). Interestingly, miR21 
KO mice showed a significant decrease in CD68, CCL2, and TNF-α (P < 0.001) (Fig.2. 6, 
B). Results showed that there was a significant increase in CD68, CD11b (P = 0.002 
and P = 0.003, respectively) (Fig.2.6, C, E, F, and H) and α-SMA (P < 0.001) (Fig.2. 
6, D and G) in NAFLD + MC mice when compared with NAFLD control mice alone. 
Interestingly, miR21 KO mice exposed with MC showed a significant decrease in CD68, 
CD11b, and α-SMA immunoreactivity (P < 0.001) (Fig.2.6, C–H) as compared with 
NAFLD + MC mice. The above data suggested that NOX2-induced miR21 plays a 
significant role in Kupffer cells and stellate cell activation leading to a proinflammatory 
phenotype in NASH. 
To study whether miR21 acted downstream by modulating the p-AKT-NF-κB 
signaling pathway, we analyzed the immunoreactivity as well as protein expression levels 
by Western blot analysis technique of the various components of the above pathway. 
Results showed that there was a significantly increased immunoreactivity of p-AKT and 
the p65 subunit of NF-κB in NAFLD + MC mice liver when compared with the NAFLD-
only liver (P = 0.002 and P = 0.005, respectively) (Fig.2.7, A–D) as well as in the Western 
blot analysis (P < 0.001 and P < 0.001, respectively) (Fig.2.7, F–H). miR21 KO mice 
exposed to MC showed a significant decrease in p-AKT and p65 immunoreactivity (P < 
0.001 and P = 0.002, respectively) (Fig.2.7, A–D) as well as in the Western blot analysis 
(P < 0.001 and P = 0.005, respectively) (Fig.2.7, F–H). We also conducted mRNA 
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expression of the NF-κB subfamily gene such as RelA, p65, and NF-κB1 (P105). Results 
showed that mRNA expression of RelA and P65 were significantly increased in these 
genes in NAFLD + MC mice (P < 0.001 and P < 0.001, respectively), whereas miR21 KO 
mice showed decreased expression of P65 gene in comparison with NAFLD only (P < 
0.001) (Fig.2.7, E). NF-κB-p105 subfamily showed similar increased expression patterns 
in the NAFLD + MC group and a subsequently decreased expression in miR21 KO mice, 
but the change was not significant (Fig.2.7, E). The above data suggested that miR21 not 
only increased the activity of NF-κB but also increased transcription of NF-κB family 
genes. 
To reconfirm the mechanisms in vitro, NOX2-miR21-NF-κB signaling pathway 
was examined in immortalized rat Kupffer cells. The Kupffer cells were primed with leptin 
and exposed to MC alone or together with NOX2 inhibitor, DMPO (free radical scavenger), 
FBA (peroxynitrite inhibitor), and miR21 inhibitor (miR21 inh). The results showed a 
significant increase in miR21 expression in leptin-primed Kupffer cells exposed with MC 
(leptin + MC) when compared with leptin alone, MC alone, or vehicle control (P < 0.05) 
(Fig.2.8, A). Leptin-primed cells coexposed with MC and either Apo or FBA showed a 
significant decrease in miR21 expression (P < 0.05) (Fig.2.8, A). These data showed that 
miR21 expression was mediated by NOX2-dependent oxidative stress and was primarily 
in Kupffer cells. We used immunofluorescence staining to understand whether this NOX2-
mediated miR21 expression caused Kupffer cell activation. Results showed that there was 
a significant increase in the immunoreactivity of CD68 in the leptin-primed cells exposed 
with MC as compared with vehicle control, leptin-, or MC-treated cells (Fig.2.8,B, i–
iv, 2.8, C, iii–iv, and 2.8, D). Interestingly, leptin-primed cells cotreated with MC and Apo, 
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DMPO, FBA, and miR21 inh showed a significant decrease in CD68 immunoreactivity 
(Fig.2.8, B, v–viii and 2.8, D). The above results suggested a strong role of NOX2-miR21-
NF-κB pathway in the activation of Kupffer cells. 
Exogenous PP2A inhibitor MC increases M1 phenotype in Kupffer cells via NOX2-
miR21-dependent pathway. 
Kupffer cells (resident liver macrophages) play a significant role in liver 
immunology. M1 phenotype of Kupffer cells is characterized by the release of high levels 
of proinflammatory cytokines [80], adaptation to an elongated morphology [81], activation 
of inducible nitric oxide synthase (iNOS), and release of NO [82]. We performed 
immunofluorescence imaging of β-tubulin for assessment of altered morphology, iNOS, 
and measured the NO release from Kupffer cells. Leptin-primed Kupffer cells exposed 
with MC showed an elongated morphology (Fig.2.9, A, iii), increased iNOS expression 
(Fig.2.9, B, iii), and NO release (Fig.2.9, C) as compared with control, leptin, or MC 
exposed alone. However, Kupffer cells coexposed with Apo, DMPO, miR21 inhibitor, or 
FBA showed normal cell morphology (Fig.2.9, A, v–viii), decreased iNOS expression 
(Fig.2.9, B, v–viii), and NO release (P < 0.05) (Fig.2.9, C). The above results suggested 
that MC-mediated NOX2-miR21 axis modulated the M1 phenotype of Kupffer cells and 
generated subsequent proinflammatory response. 
Exogenous PP2A inhibitor-induced NOX2 and ROS activates hepatic stellate cells. 
To show the exogenous PP2A inhibitor-induced profibrogenic signaling in 
NAFLD, we studied the hedgehog signaling mechanisms in an in vitro setup. Leptin-
primed and MC-treated hepatic stellate cells were coexposed with Apo, DMPO, miR21 
inhibitor, and FBA to test the role of NOX2 mediators or miR21 in liver fibrosis. 
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Immunofluorescence images of α-SMA (stellate cell activation marker) showed a 
significant increase in leptin-primed stellate cells exposed with MC when compared with 
control, leptin, and MC alone groups (P < 0.001) (Fig.2.10, A, i–iv and 2.10, B). 
Interestingly, the cells coexposed with Apo, DMPO, FBA, and miR21 inh showed 
significant decreases in α-SMA immunoreactivity as compared with leptin-primed cells 
exposed with MC (P < 0.001) (Fig.2.10, A, iv–viii and 2.10, B). Results also suggested that 
activation of stellate cells were mediated by MC-induced NOX2 and oxidative stress 
instead of the NOX2-miR21 axis. 
Exogenous PP2A inhibitor MC activates NOX2 via AKT pathway. 
To show the mechanistic link between the exogenous PP2A inhibitor and its 
subsequent activation of NOX2 both in vivo and in vitro, we conducted experiments in 
immortalized Kupffer cells. Leptin-primed cells were incubated with either MC, a standard 
PP2A inhibitor, or an AKT inhibitor. Results showed that MC alone or leptin-primed MC 
groups had a significant increase in NOX2 activation (P < 0.05) (Fig.2.11, A–D). A 
standard PP2A inhibitor also mimicked the results obtained by MC. Interestingly, AKT 
inhibitor treatment in both leptin-primed MC or PP2A inhibitor groups showed a 
significant decrease in the NOX2 activation, suggesting that NOX2 activation was 
primarily due to the AKT pathway (P < 0.05) (Fig.2.11, A–D). Since NOX2-derived 
peroxynitrite was paramount to the NASH pathology caused by exogenous PP2A inhibitor, 
we analyzed whether the AKT pathway was important for the generation of NOX2-induced 
ROS. Results showed that MC alone or leptin-primed MC groups had a significant increase 
in peroxynitrite generation as exhibited by 3NT levels (P < 0.05) (Fig.2.12, A–D). A 
standard PP2A inhibitor also mimicked the results obtained by MC. Interestingly, AKT 
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inhibitor treatment in both leptin-primed MC or PP2A inhibitor groups showed a 
significant decrease in the 3NT levels, suggesting that NOX2 activation-induced 
peroxynitrite generation was primarily due to the AKT pathway (P < 0.05) (Fig.2.12, A–
D). A mechanistic summary of the study has been provided in (Fig.2.13). 
2.4 DISCUSSION 
Our studies indicate for the first time, to the best of our knowledge, the role of 
exogenous PP2A inhibitors in exacerbating NAFLD pathology and provide a mechanistic 
basis of advancing the progression of NAFLD via NOX2-mediated miR21 (Fig.2.13). The 
results reported herein show that the administration of MC-LR, a proven environmental 
hepatotoxin and a PP2A inhibitor, caused increased inflammation, increased activation of 
stellate cells, and advanced fibrotic lesions in NAFLD. Furthermore, the results showed a 
decreased hepatic steatosis concomitant to the progression of liver injury as indicated by 
increased serum ALT levels. Our novel histological assessment tool developed by our 
collaborators at Biocellvia also showed a significant increase in fibrosis area in the liver, 
which was subjected to exogenous PP2A inhibitor administration. 
We and others have shown previously that NOX2 plays a significant role in 
promoting NASH and its fibrotic pattern. To understand the role of exogenous PP2A 
inhibition and its relationship with NASH pathogenesis, we studied the activation of 
NOX2. Our results of increased NOX2 activation following inhibition of PP2A and 
subsequent increases in protein levels of macrophage activation marker CD68 and stellate 
cell activation marker α-SMA while attenuation of all the above markers in p47 phox KO 
mice suggested that PP2A inhibition induced a strong NOX2 activation both in vivo and 
in vitro. Strikingly, PP2A-induced NOX2 activation and its downstream association with 
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inflammation and extracellular matrix deposition were also associated with increased 
levels of miR21. Interestingly our results showed an increase in PP2A protein levels 
following MC administration in mice, whereas human NASH samples showed a decrease 
in the same protein. Since PP2A inhibition is an enzymatic process, it is clear from our 
results that the activity of the protein is more relevant for the pathology rather than the 
levels of the same protein in the liver. 
Studies show that miR21 has a prominent role in NAFLD fibrosis, and NOX2-
induced downstream signaling through peroxynitrite generation can induce miR21 
expression [57]. Our results of increased levels of miR21 both in vivo and in vitro and its 
restricted levels in the presence of either a gene deletion of NOX2 cytoplasmic subunit 
(p47 phox KO mice) or Apo confirmed such a hypothesis. In addition, in vitro results using 
peroxynitrite scavenger FBA showed a decrease in miR21 levels, suggesting strongly that 
NOX2-derived peroxynitrite was responsible for the induction of higher miR21 levels in 
the liver. The higher miR21 increased liver inflammation via the phosphorylation of AKT 
and subsequent activation of NF-κB, a proven pathway for inflammation in the liver and 
other organs. 
It is widely accepted that liver injury in progressive NAFLD is accompanied by a 
parallel decrease in steatosis, and simple hepatic steatosis might be a benign process in the 
majority of patients, thus signifying that NASH can be a separate disease with different 
pathogenesis [12]. Our report confirms the previous findings by showing a decrease in 
mean vesicle size, which is correlative of a subsequent decrease in steatosis area. Studies 
show that free fatty acid delivery to the liver and triglyceride accumulation is a prime cause 
in liver fat accumulation, and together they may exert protective functions [12]. The above 
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fact may be supported by studies that show inhibition of diacyl glycerol acyltransferases 
1/2, principal enzymes in triglyceride synthesis in the liver, leads to increased liver injury, 
whereas overexpression protects the liver from macrophage activation and their 
accumulation in the liver lobule [83, 84]. Interestingly, PP2A plays a significant role in 
promoting hepatic steatosis. It does so via positively regulating SREBP1-C, a prime 
mediator of hepatic lipogenesis [85]. Thus, inhibiting PP2A in our studies rightly resulted 
in decreased steatosis area and the mean vesicle size that correlated strongly with increased 
inflammation and fibrosis in an underlying condition of NAFLD. It is also striking that p47 
phox-deficient mice and miR21 KO mice in which liver was minimal had higher steatosis 
as shown by decreased lipid droplets/vesicle size. The results in these KO mice are very 
significant since NASH-associated inflammation has been shown to decrease steatosis, and 
both of these genes may represent a yet unidentified metabolic switch that can lead to 
reprogramming of liver metabolism in NASH. 
Subsequent to miR21-induced inflammation, the said pathway also was 
instrumental in causing increased α-SMA levels, a marker for stellate cell activation. 
Interestingly, all these downstream events of liver injury associated with progressive 
phases of NAFLD were inhibited using NOX2 inhibitors. Furthermore, our studies also 
showed a distinct mechanism of PP2A-induced NOX2 activation. Use of AKT inhibitor in 
Kupffer cells primed with leptin failed to either induce NOX2 activation or generation of 
peroxynitrite, suggesting that PP2A might be activating NOX2 via AKT. The above results 
may be a significant finding to advance our understanding of upstream modulation of 
NOX2 via inhibition of PP2A. Furthermore, protein phosphatases may be negatively 
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regulating the redox pathways in NAFLD, thus exerting a positive role in the prevention 
of NAFLD progression to a more progressive phenotype. 
In summary, the results assume tremendous significance in NASH pathogenesis 
since PP2A inhibition both via endogenous and exogenous routes can be a cause of concern 
in the overall scenario of NAFLD incidences around the globe. NAFLD progression to 
NASH, though, is restricted only to a small percentage of patients with NAFLD; it is likely 
that the “multiple hit paradigm” may be in play. Furthermore, our studies of PP2A 
inhibition leading to increased fibrotic lesions in NAFLD thus also might be useful in 
dealing with the exogenous threats from the environment as posed by increased incidences 
of harmful algal blooms worldwide. 
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Figure 2.1 Exogenous protein phosphatase 2A (PP2A) inhibition in mouse liver 
exacerbates nonalcoholic fatty liver disease (NAFLD) pathology. Qualitative and 
quantitative image analysis of microcystin (MC) effects on liver steatosis and fibrosis 
induced in an NAFLD mouse model. A: representative histological images of liver 
sections stained with hematoxylin-eosin (H&E), from lean mouse control and lean mouse 
+ MC (n = 3), wild-type mouse NAFLD, and NAFLD + MC (n = 3). B: representative 
histological images of the same groups of mice stained with picrosirius red (PicroS). 
Images were taken at ×20 magnification. C: quantification of serum alanine 
aminotransferase (ALT) level and comparison between control (lean and NAFLD) and 
MC-tested groups. Automatic digital-imaging quantification of steatosis area (%) (D), 
mean vesicle size (µm2) (E), fibrosis area (%) (F), and liver tissue density (%) (G) in lean 
and NAFLD groups. H: Western blot analysis of β-actin and PP2A protein levels in the 
liver homogenates of control (lean and NAFLD) and MC-tested groups. I: morphometric 
band analysis of PP2A normalized against β-actin. The y-axis depicts the PP2A to β-actin 
ratio. J: quantitative RT-PCR (qRT-PCR) analysis of mRNA expression of PP2AR 
subunit in liver. K: qRT-PCR analysis of mRNA expression of PP2AC subunit in the 
liver for control (lean and NAFLD) and MC-tested groups. L: Western blot analysis of β-
actin and PP2A protein levels in the human liver homogenates comparing control with 
nonalcoholic steatohepatitis (NASH). M: morphometric band analysis of PP2A 
normalized against β-actin. The y-axis depicts the PP2A-to-β-actin ratio. N: qRT-PCR 
analysis of mRNA expression of PP2AR5D subunit in liver. O: qRT-PCR analysis of 
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mRNA expression of PP2ACB subunit in liver comparing control with NASH. *P < 0.05. 
Results were expressed as means ± SE. 
 
 
Figure 2.2. Protein phosphatase 2A inhibition by microcystin (MC) activates Kupffer cells 
and hepatic stellate cells and induces an inflammatory surge in mouse liver. Representative 
histological images of liver sections immunostained with CD68 (A), α-smooth muscle actin 
(SMA) (B), and CD11b (C) from lean mouse, lean mouse + MC, nonalcoholic fatty liver 
disease (NAFLD), and NAFLD + MC (n = 3/group). Images were taken at ×20 
magnification. Morphometric analysis of CD68 (D), α-SMA (E), and CD11b (F) in lean, 
lean + MC, NAFLD, and NAFLD + MC groups (n = 3/group). Morphometric analysis was 
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3 
ROIs/liver section). Quantitative RT-PCR analysis of mRNA expression of CCL2 (G), 
TNF-α (H), and CD68 (I), in lean, lean + MC, NAFLD, and NAFLD + MC livers. The 
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mRNA expressions were normalized with 18s and presented as fold change of lean group. 






Figure 2.3. The activation of Kupffer cells, hepatic stellate cells, and an inflammatory surge 
in microcystin (MC)-exposed livers are mediated by NADPH oxidase 2-dependent 
oxidative stress. A: representative images of P47 phox (red) and GP91phox (green) 
immunofluorescence counterstained with DAPI (blue); colocalization indicated by arrows. 
Images were taken at ×40 magnification. B: representative images of CD68 (red) and GP91 
phox (green) immunofluorescence counterstained with DAPI (blue), from lean, lean + MC, 
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nonalcoholic fatty liver disease (NAFLD), and NAFLD + MC (n = 3/group). 
Colocalization was indicated by a circle. Images were taken at ×60 magnification. C: 
morphometric analysis of P47 phox (red) and GP91 phox (green) colocalization expressed 
in percentage of positive colocalized immunoreactive area per region of interest (ROI) (3 
ROIs/liver section, n = 3 each group). D: quantitative RT-PCR (qRT-PCR) analysis of 
mRNA expression of P47 phoxin lean and NAFLD groups treated with MC, expressed as 
fold change of lean control group. Representative immunohistochemistry images depicting 
3-nitrotyrosine (3NT) (E), CD68 (F), α-smooth muscle actin (SMA) (G), and CD11b (H) 
expression in NAFLD, NAFLD + MC, and P47 phox knockout (KO) groups treated with 
MC. All immunohistochemistry images were taken at ×20. Morphometric analysis of 3NT 
(I), CD68 (J), α-SMA (K), and CD11b (L) immunoreactivity in NAFLD, NAFLD + MC, 
and P47 KO mice treated with MC, expressed in percentage of positive immunoreactive 
area per ROIs (n = 3/group, 3 ROIs/liver section). qRT-PCR analysis of mRNA expression 
of CD68, CCL2 and TNF-α in NAFLD and P47 KO mice treated with MC, expressed as 




Figure 2.4. The protein phosphatase 2A inhibition activates NADPH oxidase 2-dependent 
oxidative stress in Kupffer cells. Leptin was used to mimic a nonalcoholic fatty liver 
disease (NAFLD) condition. Kupffer cells were exposed to 100 ng/mL leptin for 24 h. A: 
representative immunofluorescence images depicting P47 phox (red) and GP-91 phox 
(green) immunolabelling, counterstained with DAPI (blue), in control, leptin, microcystin 
(MC), leptin + MC, and leptin + MC + apocynin (Apo) rat Kupffer cells groups. Images 
were taken at ×60 magnification. B: morphometric analysis of the number of cells 
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expressing a colocalization for P47 phox and GP91 phox. The y-axis shows colocalization 
events/100-cell unit (n = 3, analysis from 3 separate microscopic fields). *P < 0.05. Results 
were expressed as means ± SE. 
 
 
Figure 2.5. Protein phosphatase 2A inhibitor microcystin (MC) synergistically increases 
NADPH oxidase 2 (NOX2)-dependent tyrosine nitration in Kupffer cells. NOX2-
dependent tyrosin nitration marker 3-nitrotyrosine (3NT) immunoreactivity in leptin-
activated rat Kupffer cell line. A: representative immunofluorescence images depicting 
3NT immunoreactivity in control, leptin, MC, leptin + MC, leptin + MC + apocynin (Apo), 
leptin + MC + DMPO, and leptin + MC + phenyl boronic acid (FBA) Kupffer cells groups. 
Images were taken at ×20 magnification. B: morphometric analysis of the number of 
immunoreactive cells for 3NT in control and treated groups. The y-axis shows 
immunoreactive events/100-cell unit (n = 3, analysis from 3 separate microscopic fields). 





Figure 2.6. Exogenous protein phosphatase 2A inhibitor-induced oxidative stress triggers 
miR21-dependent NF-κB pathway activation in nonalcoholic steatohepatitis. Histological 
features and morphometric analysis of CD68, α-smooth muscle actin (SMA), and CD11b 
expression in nonalcoholic fatty liver disease (NAFLD) and miR21 knockout (KO) mice. 
A: quantitative RT-PCR (qRT-PCR) analysis of miRNA expression of miR21 in NAFLD, 
NAFLD + microcystin (MC), and P47 KO + MC groups, expressed as fold change of 
NAFLD group. B: qRT-PCR analysis of mRNA expression of CD68, CCL2, and TNF-α, 
in NAFLD, NAFLD + MC, and miR21 KO groups. mRNA expression is represented as 
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fold change of NAFLD. Representative immunohistochemical images depicting CD68 (C), 
α-SMA (D), and CD11b (E) immunoreactivity in NAFLD, NAFLD + MC, and miR21 KO 
groups. Morphometric analysis of CD68 (F), α-SMA (G), and CD11b (H) immunolabelling 
in the various treated groups. The y-axis shows the percentage of positive immunoreactive 
area/region of interest (ROI) (n = 3, analysis from 3 separate microscopic fields). *P < 
0.05. Results were expressed as means ± SE. 
 
 
Figure 2.7. Exogenous protein phosphatase 2A inhibitor-induced miR21 upregulation 
acted downstream by modulating the p-AKT-NF-κB signaling pathway. A and B: 
representative immunohistochemical images depicting p-AKT and P65 immunoreactivity 
in nonalcoholic fatty liver disease (NAFLD), NAFLD + microcystin (MC), and miR21 
knockout (KO) + MC groups. C and D: morphometric analysis of p-AKT and P65 
immunolabelling in various treated groups; y-axis shows the percentage of positive 
immunoreactive area/region of interest (ROI) (n = 3, analysis from 3 separate microscopic 
fields). E: quantitative RT-PCR analysis of mRNA expression of RelA, NF-κB-P105, and 
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P-65 in NAFLD, NAFLD + MC, and miR21 KO groups, expressed as fold change of 
NAFLD. F: Western blot analysis of β-actin, p-AKT, AKT, and P65 protein levels in the 
liver homogenates in NAFLD, NAFLD + MC, and miR21 KO groups. G: morphometric 
band analysis of p-AKT normalized against AKT. The y-axis depicts the p-AKT-to-AKT 
ratio. H: morphometric band analysis of P65 normalized against β-actin. The y-axis depicts 
the P65-to-β-actin ratio in the liver of NAFLD, NAFLD + MC, and miR21 KO groups, 









Figure 2.8. NADPH oxidase 2-miR21-NF-κB signaling pathway in microcystin (MC)-
exposed immortalized rat Kupffer cells. A: miR21 expression in control, leptin, MC, leptin 
+ MC, leptin + MC + apocynin (Apo), leptin + MC + DMPO, leptin + MC + miR21 
inhibitor (inh), and leptin + MC + phenyl boronic acid (FBA). miRNA expression is 
represented as fold change of control group. B: representative immunofluorescence images 
depicting CD68 (red), counterstained with DAPI (blue), in control and tested rat Kupffer 
cell groups. Images were taken at ×20 magnification. C: immunofluorescence images 
depicting CD68 (red), counterstained with DAPI (blue), in leptin + MC and MC groups of 
rat Kupffer cells. Images were taken at ×40 magnification. D: morphometric analysis of 
CD68 immunoreactivity; y-axis shows the percentage of activated Kupffer cells per region 
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of interest (n = 3, analysis from 3 separate microscopic fields). *P < 0.05. Results were 
expressed as means ± SE. 
 
Figure 2.9. Exogenous protein phosphatase 2A inhibitor exposure increases M1 phenotype 
in Kupffer cells. Immunoreactivity of β-tubulin and inducible nitric oxide synthase (iNOS) 
and quantification of nitirc oxide in leptin-activated rat Kupffer cell line. A and B: 
immunofluorescence images depicting β-tubulin and NOS2 (iNOS) (red), counterstained 
with DAPI (blue), in control, leptin, microcystin (MC), leptin + MC, leptin + MC + 
apocynin (Apo), leptin + MC + DMPO, leptin + MC + miR21 inhibitor (inh) and leptin + 
MC + phenyl boronic acid (FBA) groups of rat Kupffer cells. Images were taken at ×60 
magnification. C: nitric oxide release measured as total nitrite (μM) in variously treated 




Figure 2.10. Exogenous protein phosphatase 2A inhibitor exposure activates hepatic 
stellate cells via NADPH oxidase 2-miR21 axis. A: immunofluorescence images depicting 
α-smooth muscle actin (SMA) (green), counterstained with DAPI (blue), in control, leptin, 
microcystin (MC), leptin + MC, leptin + MC + apocynin (Apo), leptin + MC + DMPO, 
leptin + MC + miR21 inhibitor (inh), and leptin + MC + phenyl boronic acid (FBA) groups 
of 8B rat hepatic stellate cells. Images were taken at ×40 magnification. B: morphometric 
analysis of α-SMA immunoreactivity; y-axis shows the percentage of α-SMA-positive 
cells per region of interest (ROI) (n = 3, analysis from 3 separate microscopic fields). *P < 




Figure 2.11. Exogenous protein phosphatase 2A (PP2A) inhibitor activates NADPH 
oxidase 2 via AKT pathway. Immunoreactivity and morphometric analysis of P47 phox 
and GP91 phox expression in leptin and microcystin (MC) -treated rat Kupffer cells. A: 
immunofluorescence images depicting P47 phox (red) and GP91 phox (green) 
colocalization, counterstained with DAPI (blue), in control, MC, PP2A inhibitor (inh), 
AKT inh + MC, and AKT inh + PP2A inh. B: immunofluorescence images depicting P47 
phox (red) and GP91 phox (green) colocalization, counterstained with DAPI (blue), in 
control, leptin, leptin + MC, Leptin + PP2A inh, leptin + MC + AKT inh, and leptin + 
PP2A inh + AKT inh. C and D: quantitative analysis of the number of colocalized cells 
for P47 phox and GP91 phox in the various Kupffer cell line groups; y-axis shows 
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colocalization events/100-cell unit (n = 3, analysis from 3 separate microscopic fields). 
*P < 0.05. Results were expressed as means ± SE. 
 
Figure 2.12. Exogenous protein phosphatase 2A (PP2A) inhibitor-activated NADPH 
oxidase 2 generates oxidative stress via AKT pathway. Immunoreactivity and 
morphometric analysis of 3-nitrotyrosine (3NT) expression in rat Kupffer cells. A: 
immunofluorescence images depicting 3NT immunoreactivity (red), counterstained with 
DAPI (blue), in control, microcystin (MC), PP2A inhibitor (inh), MC + AKT inh, and 
PP2A inh + AKTinh. B: immunofluorescence images depicting P47 phox (red) and GP91 
phox (green) colocalization, counterstained with DAPI (blue), in control, leptin, leptin + 
MC, leptin + PP2A inh, leptin + MC + AKT inh, and leptin + PP2A inh + AKT inh. C and 
D: quantitative analysis of the number of immunoreactive cells for 3NT immunoreactivity 
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in various treated groups; y-axis shows colocalization events/100-cell unit (n = 3, analysis 
from 3 separate microscopic fields). *P < 0.05. Results were expressed as means ± SE. 
 
Figure 2.13. Mechanism of protein phosphatase 2A (PP2A) inhibition-induced 
nonalcoholic fatty liver disease (NAFLD) pathology. Graphical representation showing 
upregulation of miR21 via NADPH oxidase 2 (NOX2) activation by exogenous PP2A 
inhibitor (microcystin) in Kupffer cells, leading to transcriptional upregulation of 
inflammatory cytokines, M1 polarization, and fibrosis in NAFLD liver. α-SMA, α-smooth 












EXOGENOUS PP2A INHIBITOR IN NAFLD CAN LEAD TO 
PYROPTOSIS AS WELL AS HEDGEHOG SIGNALING PATHWAY 
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Abstract: 
Chronic Microcystin-LR exposure can cause serious liver injury. Liver injury can 
have multiple outcomes that can be studied in molecular pathology. One of them is a 
pyroptosis, which is a type of different types of cell death mechanisms. It  is a result of 
releasing caspase 1 and its activation. Gasdermine D is a prevalent marker for pyroptosis. 
The second outcome is HH-signaling network's deregulation that may contribute to the 
pathogenesis and sequelae of liver damage resulting from metabolic syndrome. We in the 
previous study showed that MC-LR toxicity was be involved in the PP2A signaling 
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pathway and various cellular activities. The purpose of the present study was to investigate 
the impact of microcystin on hepatic pyroptosis as well as on hepatic fibrosis in vitro. 
Combined immunofluorescence imaging of transmembrane proteins E-Cadherin and 
GSDMD showed significant enhanced colocalization events in cells that is primed with 
leptin and exposed to MC as compared with the other groups especially the 
pharmacologically inhibited one. In addition, inhibitors which are added to leptin primed 
MC exposed stellate cell showed significant deceased in Gli1, PTCH1, IHH, SHH gene 
expression. Thus, increased pyroptosis as well as activate profibrotic hedgehog signaling 
pathway and activated stellate cells happened via NOX2 mediated ROS. 
3.1 INTRODUCTION 
Microcystin is known as a potent liver toxin that is available in pond waters that 
have the blue-green alga such as Microcystis aeruginosa [44]. The major determining factor 
of microcystin hepatotoxicity has the ability to accumulate in liver cells through 
mechanisms that facilitate its uptake [51]. OATP transporter family have been proven in 
research that they are responsible for the liver uptake as it shows that Oatp1b2-null mice 
has absence of the liver toxicity after being exposed to microcystin [46, 86]. The main 
mechanism of microcystin toxicity is by Protein phosphatase 2A (PP2A) inhibition [51]. 
We have shown that Microcystin is exacerbating NASH in NAFLD condition [87].  
Nonalcoholic steatohepatitis (NASH) is a hepatic form of metabolic syndrome that 
is a result of the most widely known model of "two-hits" or "multiple-hits" hypothesis [12, 
88]. It is started with long term liver fat accumulation, which is resulting in the primary hit. 
The main impact of asymptomatic primary hit is that it makes the liver more susceptible to 
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secondary hits that came as a result of exposure to an environmental toxin that causes 
additional stress, such as oxidative stress, as well as subsequent lipid peroxidation [6, 11, 
89]. This will be followed by release of proinflammatory cytokines, and adipokines that 
cause the inflammation as well as fibrosis. Cellular death is associated with NASH 
conditions as a result of release of proinflammatory cytokines as well as the oxidative stress 
[90]. 
Eukaryotic cells are vulnerable to cell death in NASH condition where the loss of 
demarcation of cell margins and organelles can be seen microscopically happening in the 
intact tissue [90]. In  eukaryotic cells,  a wide range of cell death mechanisms has been 
shown by many researchers using molecular pathology markers. There are many 
mechanisms for cellular deaths such as apoptosis , necrosis, and pyroptosis [91]. One of 
these mechanisms is pyroptosis, which is a distinctive type of programmed cell death that 
is dependent on Caspase 1 activation, and it is characterized by release of pro-inflammatory 
cytokines such as of IL-1β and IL-18 , as well as cellular swell, burst and death [92].   
There is a usual association between NASH pathophysiology and fibrosis 
particularly on its late stage as is shown by different research in molecular pathology of 
NAFLD [93-95]. Hepatic fibrosis is strongly associated with the aggregation of 
extracellular matrix (ECM) proteins in the liver parenchyma, primarily  type I collagen, 
which is a characteristic in many chronic liver pathologies. This happens in liver as a 
response to wound-healing in chronic liver injury. The primary collagen-producing cells 
in the liver parenchyma were recognized as hepatic stellate cells (HSCs) [96]. We have 
already shown that Microcystin is causing activation of hepatic stellate cells (HSCs) [87]. 
This step is a crucial cellular event in a hepatic fibrosis [97]. It has been known that 
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Hedgehog signaling pathway can contribute considerably to liver fibrosis as well as in the 
process of activation of HSC [98]. 
The purpose of the present study was to investigate the impact of Microcystin as 
PP2 inhibitor to induce pyrptosis as well as on hepatic fibrosis in vitro assessment. 
3.2 MATERIALS AND METHODS 
Materials: 
Specific chemicals such as Microcystin-LR was purchased from Cayman (Ann 
Arbor, MI), and Leptin was purchased from BioVision (Milpitas, CA). Anti-E Cadherin 
primary antibody was purchased from Abcam (Cambridge, MA). Anti-Gasdermin D also 
was purchased from Santacruz Biotechnology (Dallas, TX). Fluorescence conjugated 
(Alexa fluor) secondary antibodies that used based on primary antibodies as well as 
ProLong Gold antifade mounting media with DAPI were bought from Thermo Fisher 
Scientific (Waltham, MA). miR21 inhibitor was bought from Qiagen (Valencia, CA). 
Phenyl Boronic Acid (FBA) and the spin trap 5,5 dimethyl-1- pyrroline N-oxide DMPO 
were  bought from Alexis biochemical (San Diego, CA)  All other chemicals not specified 
above were analytical grade and bought from Sigma Chemical Company. 
Kupffer Cell Culture and Treatments 
Immortalized rat Kupffer cell line (SV40) has been grown and cultured as described 
in the chapter 2. The cells were either kept without treatment (control) or treated with either 
leptin (100ng/ml), MC-LR (20μM), or leptin followed with MC-LR at the same doses. 
Certain cell groups have been incubated with pharmacological inhibitor first such as 
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Apocynin (100 μM) , Phenyl Boronic Acid (FBA) (100 μM) , (100 mM) the spin trap 5,5 
dimethyl-1- pyrroline N-oxide DMPO , or (20 µM) miR21 inhibitor. Then, followed by 
incubation with leptin, and  microcystin at the same doses. All cells groups immediately 
after 24 hours incubation period were then plated on coverslips MatTek Corp, (Ashland, 
MA) for immunofluorescence staining according to our lab protocol that specified in 
chapter 2. Cells were incubated specifically with primary antibodies anti- Gasdermin D, 
and anti- E Cadherin, Then, cells groups followed by species-specific Alexa Fluor 633 and 
488 in order to show the colocalization events. The stained cells attached on the coverslips 
were mounted on slides with ProLong Gold antifade reagent with DAPI (Life 
Technologies) and viewed under 60X oil magnification with an Olympus BX51 
microscope. 
Stellate Cells Culture and Treatments: 
Immortalized rat hepatic stellate cell line (8B) kindly provided to us by Dr. Anna 
Mae Diehl (Duke-Gastroenterology), were cultured as described in the chapter 2. The cells 
were then treated the same way regarding to groups and treatment as Kupffer cells. Then 
immediately after treatments has completed, the cells were lysed in Trizol for mRNA 
extraction. mRNA levels of gene expression of Immortalized rat hepatic stellate cell line 
(8B) were measured using our standard laboratory protocol by using quantitative real-time 
reverse transcription-polymerase chain reaction (qRT-PCR). The primers used for Real-






Table 3.1. Primer sequences for the different target genes. 
Gene Primer sequence 


















All cellular studies in vitro have been repeated at least three times (n = 3). The 
statistical analysis was carried out by unpaired t-test and ANOVA. For all analyses, P < 
0.05 was considered statistically significant. 
3.3 RESULTS 
Microcystin induces Pyroptosis via NOX2-miR21 dependent pathway 
Pyroptosis is a novel caspage-1 dependent lytic cell death process mediated by 
formation of inflammasome complex [99]. Previous studies suggest that NOX dependent 
59 
 
ROS and NF-kB activation modulate inflammasome formation and subsequent pyroptosis 
[100]. Recently, pyroptosis defined as gasdermin D (GSDMD)-mediated programmed 
necrosis since GSDMD represent a substrate for both caspage-1 and caspage-11/4/5 which 
are mediators of pyroptosis [101]. Next, we investigated whether MC induced NOX2-
miR21-Nf-kB pathway activate GSDMD mediated pyroptosis in NASH. Dual 
immunofluorescence imaging of transmembrane protein E-Cadherin and GSDMD showed 
significant increased colocalization events in leptin primed cells exposed with MC as 
compared with vehicle control, leptin or MC treated cells (Fig.3.1, A,B). Interestingly, 
leptin primed cell co-treated with MC and Apo, DMPO, FBA and miR21 inhibitor showed 
significant decreased in E-Cadherin-GSDMD colocalization event (Fig.3.1,A,B). Results 
suggest that the increased localization of GSDMD to the membrane causes membrane 
permeability and GSDMD mediated cell death, thus increased pyroptosis. 
Microcystin induced NOX2 and ROS activate profibrogenic hedgehog signaling in 
hepatic stellate cells  
Next, we investigated whether MC induced NOX2-miR21 axis or NOX2 
mediators activate stellate cells, pro-fibrogenic hedgehog signaling pathway and 
subsequent fibrosis. Leptin primed hepatic stellate cell were exposed with MC and co-
exposed with Apo, DMPO, FBA and miR21 inhibitor to test the role of NOX2 mediators 
or miR21 in liver fibrosis. Results suggest that activation of stellate cells is mediated by 
MC induced NOX2 and oxidative stress instead NOX2-miR21 axis. Further, to correlate 
MC induced activation of profibrotic hedgehog signaling pathway, the mRNA 
expression of Gli1 gene (a hedgehog transcription factor), Patched 1 (PTCH1), Indian 
hedgehog (IHH) and Sonic hedgehog (SHH) were analyzed. The leptin primed stellate 
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cells exposed with MC showed significant increase in Gli1, PTCH1, IHH, SHH gene 
expression as compared to control, leptin or MC alone groups (Fig. 11B-E). However, 
Apo, DMPO, FBA or miR21 treatment to leptin primed MC exposed stellate cell showed 
significant deceased in Gli1, PTCH1, IHH, SHH gene expression (Fig.3.2,B-E). Results 
suggest that NOX2 mediated ROS activate profibrotic hedgehog signaling pathway and 
activate stellate cells. 
3.4 DISCUSSION 
The present study builds on our findings which we have reported in chapter 2.  We 
investigated the mechanisms by which chronic exposure to MC-LR causes liver injury 
through activation of NOX-2 , profibrogenic hedgehog signaling and pyroptosis in hepatic 
stellate cells and Kupffer cells, in NAFLD.  
We found that there was enhanced concentrations of Gli1, patched (PTCH1) and 
sonic hedgehog ligand SHH, which are significant mediators of the hedgehog signaling 
pathway which other research group had earlier shown to play a prominent part in liver 
fibrogenesis [102-104]. Interestingly, all these increases in the genes of the hedgehog 
signaling pathway following microcystin exposure that are associated with progressive 
phases of NAFLD were decreased when  NOX2 inhibitors ,miR21 inhibitor, or FBA , were 
applied. However, we have seen in hepatic stellate cell (HSC) culture that MC enhanced 
the activation as well as profibrogenic proliferation of HSCs, which may have been through 
enhanced hedgehog signaling pathway  via NOX2 dependent pathway. 
One of the main regulators among others which are responsible for the growth of 
humans is the Hedgehog signaling pathway. Essentially, it regulates the progress of furrow 
by induction of at least two signals. The downstream of the hedgehog signaling can behave 
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as a long-range signaling molecule on anterior unvarying cells and prompts the expression 
of Hairy [105]. The pathway is being studied by the field of molecular biology, as it is of 
equal importance throughout the development of embryos. Namely, the Hedgehog 
signaling is a pathway which passes to the cells of the embryo the necessary information 
for proper cell differentiation. Different parts of the embryo concentrate different amounts 
of Hedgehog signaling proteins. Moreover, it is discovered that the malfunctioning of 
Hedgehog signaling is correlated with diseases such as basal cell carcinoma [106]. 
Furthermore, in recent researches, it is found that Hedgehog signaling plays also a hallmark 
role in regulating as well as controlling adult stem cells which have the potential for 
maintaining and regenerating human tissues [107]. In addition, numerous pharmaceutical 
companies have begun developing drugs which specifically aim in targeting the Hedgehog 
signaling pathway, as it is found involved in the development of certain types of cancer  
[108]. In NAFLD, the activity of the hepatic Hedgehog signaling pathway is connected to 
the extent of the severity of hepatic injury and with the levels of  metabolic syndrome 
clinical parameters, which are expected to be predictive of advanced liver disease. Thus, 
the upregulation of the hedgehog signaling pathway can perhaps add to the pathogenesis 
and liver injury sequelae. On top of that, the increased activity of the pathway is directly 
connected with histological features of liver injury such as portal inflammation, hepatocyte 
ballooning and fibrosis. That supports further the association between Hedgehog signaling 
and the damage of the liver [109]. As is known in NASH, Hedgehog-stimulated hepatic 
stellate cells gain a pro-fibrogenic phenotype, as they transdifferentiated from epithelial-
to-mesenchymal until becoming myofibroblasts. Moreover, after they transform into 
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myofibroblasts, they gain the ability to release pro-inflammatory and chemotactic 
cytokines [102-104]. 
Using a cell culture model of NAFLD that was induced by leptin, we show that MC 
treatment could assemble Gasdermin D (GSDMD) with transmembrane protein E-
Cadherin.  Leptin treatment primed cells that were co-treated with MC and 
pharmacological inhibitors such as Apo, DMPO, FBA and miR21 showed a substantial 
decline in this assembly events. Since caspase 1 can also cleave Gasdermine D because of 
pyroptosis, this results in the translocation of the membrane where they polymerize and 
form membrane pores where it can be assembled with E-Cadherin [110]. Another result is 
the release of pro-inflammatory cytokines through these membrane pores. This can be 
showed as a distinct mechanism of PP2A-induced NOX-2 activation. 
In summary, we conclude that exposure to exogenous PP2A inhibitor such as 
microcystin can result in increased pyroptosis in Kupffer cells and activation of 
profibrogenic hedgehog signaling in hepatic stellate cells. We also conclude that these 





Figure 3.1. Exogenous PP2A inhibitorexposure induces pyroptosisin Kupffer 
cells.Immunoreactivity and morphometric analysis of Gasdermin D and E-cadherin 
expression in leptin-activated rat Kupffer cells. (A)Immunofluorescence images depicting 
Gasdermin D (GSDMD) (green) and Cadherin (red), colocalization (yellow), 
counterstained with DAPI (blue) in control, leptin, MC,leptin+MC, 
leptin+MC+apocynin,leptin+MC+DMPO, leptin+MC+miR21 inh. and leptin+MC+FBA 
groups of rat Kupffer cells. Images were taken at 60X magnification. (B) Quantification of 
the number of colocalized cells for Gasdermin D (GSDMD) and E-Cadherin 
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immunoreactivity, Y-axis shows colocalization events/100-cell unit (n=3, analysis from 




Figure 3.2.Exogenous PP2A inhibitorexposure activates profibrogenic hedgehog 
signaling in hepatic stellate cells via NOX2-miR21 axis. qRT-PCR analysis of mRNA 
expression of Gli1, PTCH1, IHH and SHH in leptin-activated rat hepatic stellate cells 
line. (A-D) qRT-PCR analysis of mRNA expression of Gli1,  IHH, PTCH1, and SHHin 
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Abstract: 
Evidence is strong for early childhood exposure effects individuals with physical , 
biological , chemical , or psychological stimuli. Results from American Academy of 
Pediatrics show that infants and children are at risk for early exposure to microcystin. 
Notably, infants and children are known to consume more water relative to their body 
weight when compared to adults and thus are at increased risk of water borne exposures to 
environmental contaminants. The present report tests the hypothesis that early childhood 
exposure to microcystin (MC), a PP2A inhibitor and a principal component of harmful 
algal blooms activate Kupffer cells and hepatic stellate cells, which are considered to be 
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crucial mediators in hepatic fibrogenesis in an underlying condition of NAFLD. Mice 
exposed to subchronic doses of microcystin-LR (MC-LR) for two weeks immediately after 
the end of weaning and with a parallel high fat diet co-exposure showed classical symptoms 
of early NAFLD linked inflammation. Cytokines and chemokines such as CD68, IL1β, 
MCP-1, and TNF-α, as well as α-SMA, hallmarks of NAFLD-linked inflammation were 
increased in the groups that were exposed to microcystin with high fat diet compared to 
the vehicle group. Also, NLRP3 KO mice showed significant decrease in the inflammation 
suggesting a decisive role of NLRP3 linked inflammasome activation and increased 
inflammation in these mice. The same trends were observed for liver injury biomarker IL-
1β, indicating a worsening outcome in liver health. Clinically, serum alanine 
aminotransferase (ALT) levels were significantly higher in the group that was primed to 
Microcystin followed by high fat feeding when compared to controls. The results suggest 
that toddlers and children might be at a greater risk of microcystin exposure and subsequent 
liver damage since data generated in mice models are highly translatable to humans. The 
results also bode well to strong clinical data that suggest increased incidences of NAFLD 
and NASH cases in children and juveniles in the US and around the developed world. 
4.1 INTRODUCTION 
Algae as well as cyanobacteria are detected in all types of aquatic environments. It 
has been published on a large number of studies that the presence of microcystins in surface 
waters that found worldwide [111]. Microcystins poses a strong risk to human health 
through drinking water. Drinking water has been reported to be contaminated by 
microcystin  in many regions of harmful algal bloom [112-115]. For instance, there was an 
event of contamination of drinking water with Microcystis toxins in Caruarù, Brazil. This 
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was the first serious outbreak that was  reported to cause  symptoms of hepatotoxicity in 
humans as similar to what has been  seen in laboratory studies. These data that came from 
dialysis center gave proof that microcystins are also potent inhibitors of Protein 
phosphatase 2A (PP2A) enzymes in humans [116, 117]. 
Early childhood exposure has the potential to have long-life effects on individuals 
exposed to physical, biological, chemical, or psychological stimuli. According to the 
American Academy of Pediatrics, infants and children are at elevated risk for early 
exposure to microcystin, a constituent of harmful algal blooms. Infants and children have 
been known to consume more water relative to their body weight when compared to adults 
and thus can incur higher risks to exposure from water-borne toxins such as microcystin. 
For example, the mean intake for water in infants and children are around 43 and 35 
ml/kg/day, respectively. These values decrease  when children are in their teen and adult 
ages,  where they have the mean water intake  of 18 and 19 ml/kg/day, respectively [118]. 
Also, children may  be at the risk from exposure to coastal blooms from recreating near 
ponds and beach shores.  
Several studies have also established that the tissues and organs of the body undergo 
fast development during fetal life as well as early infancy, during which any sort of toxic 
insult can have significant impacts [119, 120]. From progenitor cells stage, in fetus liver 
grows into a well-differentiated organ in which bile secretion can be started through 12 
weeks gestation. It requires up to two years to reach full maturity after birth, in order to 
perform complete liver function [121]. 
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We have reported in our studies that the activation of NLRP3-inflammasome in 
dysbiosis associated with NAFLD conditions following microcystin exposure [122].  
NLRP3 inflammasome is a multiprotein complex that resides inside the cell structure [123]. 
It has different parts like the cytoplasmic receptor NLRP3 or also known as inflammasome 
sensor molecule, the adaptor protein caspase-recruitment domain ASC and the effector 
protein pro-caspase 1. Upon activation, their parts are assembled together yielding several 
pro-caspase sub-units  close to each other. This pro-caspase 1 when close together within 
cytosolic multimolecular complexes, they cleave themselves in order to release the mature 
or active form, caspase 1. The activated caspase-1 further cleaves the , pro-IL-1β as well 
as proIL-18 into their mature interleukin forms IL-1β and IL-18 to be released into the 
system [92, 124-126]. 
In the present study, we used a juvenile mice model primed them with microcystin 
and fed them on high fat diet in order to investigate the role of early microcystin exposure 
in DIO model. We have chosen to investigate mechanistically whether early microcystin 
exposure triggered the NLRP3  inflammasome activation and intensified livery injury 
outcomes. 
2.2 MATERIALS AND METHODS 
Materials 
All other chemicals needed for this study were of analytical grade and were 
purchased from Sigma Chemical Company unless indicated otherwise. From Cayman 
(Ann Arbor, MI), Microcystin-LR was purchased (Ann Arbor, MI). From The Jackson 
Laboratories (Bar Harbor, ME) ,wild-type and gene-specific knockout (KO) mice 
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including NLRP3 knock out  mice were purchased. From Research Diets (New Brunswick, 
NJ), the animal diet specifically high-fat (60% KCal) (HFD) diet were purchased. From 
Abcam (Cambridge, MA), primary antibodies such as anti-CD68, anti-α-SMA, anti-3 
nitrotyrosine (3NT), anti-IL-1β, anti- GP91 phox, anti-P47phox, and anti-αSMA were 
purchased. Anti-NLRP3 and anti-ASC2 were purchased from Santacruz Biotechnology 
(Dallas, TX). From Abclonal (Woburn, MA), anti-IL18 antibody was purchased. From 
Vector Laboratories (Vectastain Elite ABC kit, Burlingame, CA), we purchased Species-
specific biotinylated conjugated secondary antibody and streptavidin-horseradish 
peroxidase. From Thermo Fisher Scientific (Waltham, MA), fluorescence conjugated 
(Alexa fluor) secondary antibodies as well as ProLong Gold antifade mounting media with 
DAPI were bought. From IHC world (Woodstock, MD), NovaUltra Special Stain Kits were 
purchased.  At AML laboratories (Baltimore, MD), paraffin embedding of the liver tissue 
sections on slides were performed. 
Mouse model  
Experimental Models Used:  
Pathogen-free, Juvenile, male mice with C57BL/6J background (Jackson 
Laboratories, Bar Harbor, ME) will be used in the study. At the age of 4 weeks, they have 
been administered with vehicle (ethanol then dissolved in PBS), or microcystin-LR (MC-
LR) (10µ/kg, 5 dosages per week), through the intraperitoneal route for two weeks before 
starting in diet regime or euthanized . A group of  injected mice were fed with a high-fat 
(60% KCal) (HFD) diet, (Research diets, New Brunswich, NJ) for 4 weeks and used as a 
model of diet-induced obesity (DIO+MC model)  until the feeding is over and they are 
euthanized. Also, another group of mice were fed with a Chow diet (Lean MC model). 
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Also, mice with vehicle were fed the regular chow diet (Lean Control model).  Another set 
of mice have not been injected with MC-RL were fed the HFD and used as (DIO model)  
in this study. An additional set of NLRP3 KO mice at the age of 4 weeks, they have been 
administered with microcystin-LR (MC-LR) at same dose. Then they had fed with HFD 
until the feeding is over and they were euthanized.  All mice will be housed with 3-5 
mice/cage at 23–24°C on a 12:12-h light-dark cycle with libitum access to food and water. 
The complete amount of mice in each group was evaluated on the basis of calculations that 
provided sufficient statistical power of 0.5. All animals have been treated in strict 
accordance with the NIH Guide for the Humane Care and Use of Laboratory Animals, and 
the experiments will be approved by the institutional review board at the University of 
South Carolina at Columbia. Mice had been euthanized at the completion of the diet regime 
or after priming and serum and liver tissue collected for further processing. Liver tissue 
sections from each mouse after euthanized were collected and fixed in 10% neutral 
buffered formalin. 
Histopathology: 
Sections of liver tissue from each mouse after were collected and fixed in 10% 
neutral buffered formalin. These Formalin-Fixed Paraffin-Embedded (FFPE) liver tissues 
were cut into 5-m thick sections. For histological examinations, liver sections slides were 
deparaffinized using standard protocol and stained with hematoxylin and eosin (H&E) and 
Picro-Sirius red using NovaUltra Special Stain Kits following manufacturer’s protocol 





Serum ALT Measurements: 
Serum alanine aminotransferase (ALT) levels were quantified and measured using 
an automated analyzer at the University of Georgia Clinical pathology core facility. 
Immunohistochemistry: 
Using standard protocol , formalin-fixed, paraffin-embedded liver tissue sections 
(5-μm thick) from all the mice groups were deparaffinized and subjected to antigen 
retrieval. The primary antibodies CD68, 3-nitrotyrosine , and TGF-β  are used at 
recommended dilutions. The rest of the experiment was explained in details in chapter 2. 
Sections were finally observed under a 20X objective using an Olympus BX51 microscope 
(Olympus, America). 
Immunofluorescence Microscopy: 
Using standard protocol , formalin-fixed, paraffin-embedded liver tissue sections 
(5-μm thick) from all the mice groups were deparaffinized and subjected to antigen 
retrieval. The primary antibodies α-SMA, NLRP3,ASC2, IL-1β, IL-18 are used at 
recommended dilutions. Species-specific anti-IgG secondary antibodies conjugated with 
Alexa Fluor 488 and Alexa Fluor 633 (Invitrogen, California, USA) ,were used against the 
appropriate primary antibodies. The rest of the experiment was explained in details in 
chapter 2. Sections were finally observed under a 40X objective using an Olympus BX51 





Quantitative Real-Time Polymerase Chain Reaction: 
Gene expression for mRNA levels from juvenile mice liver tissue were measured 
by quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR) by 
following our routine laboratory protocol. The primers used for RT-PCR in 5′ to 3′ 
orientations are provided in Table 4.1. 
Table 4.1. Primer sequences for the different target genes. 





























ASC-2  Sense: GGACAGTACCAGGCAGTTCG 
74 
 







All mice experiments were repeated three times with at least 3 mice per group (n = 
3; data from each group of 3 mice were pooled). Data were represented as mean ± S.E. The 
graphs were plotted using GraphPad Software, Inc.The statistical analysis was carried out 
by unpaired t-test and ANOVA. For all analyses, P < 0.05 was considered statistically 
significant. 
4.3 RESULTS 
Early priming with microcystin will induces liver injury  
To determine the effects of early priming exposure of MC-LR in mice immediately 
after weaning on liver parenchyma , liver histopathology as well as inflammatory markers 
were analyzed. The early primed MC-LR mice showed an increase in liver injury 
pathophysiology, as shown by increased infiltrating immune cells (early inflammation) 
when compared with lean mice that only exposed to vehicles (Fig. 4.1 A). Moreover, in 
order  to investigate if early priming with MC-LR can induce activation for both Kupffer 
cells and hepatic stellate cells, immunoreactivities of Kupffer cell activation marker CD68, 
as well as hepatic stellate cell activation marker α-SMA, were analyzed in liver tissue 
slices. Results showed that there was a significant increase in CD68 immunoreactivity in 
75 
 
early primed mice with MC-LR  as compared with Lean group of mice that primed with 
vehicle (P < 0.001) (Fig. 4.1, C, and F). These findings have been further confirmed at the 
mRNA levels of CD68 as well as the inflammatory markers. CD68 mRNA expression in 
mice that primed with MC  has increased significantly when compared with Lean mice (P 
= 0.008) (Fig. 3.1, H). Moreover, in order to test that the activation of Kupffer cells took 
part in a proinflammatory phenotype, mRNA expression of proinflammatory cytokines 
such as monocyte-chemoattractant protein-1 (MCP-1), Interleukin 1 beta (IL-1β), and 
tumor necrosis factor-α (TNF-α) were evaluated. The result showed that there was a 
significant increase in CCL2, IL-1β and TNF-α mRNA expression in mice that primed with 
MC as compared with lean mice (P < 0.001, P=0.005, and P < 0.001 , respectively) (Fig. 
3.1, H). α-SMA immunoreactivity, a characteristic of stellate cell activation, then was 
significantly increased as well in early primed mice with MC-LR  groups when compared 
with Lean mice group (P < 0.001) (Fig. 3.1, D and G). α-SMA mRNA expressions in mice 
that primed with MC-LR  have increased significantly when compared with lean mice (P 
< 0.001) (Fig. 3.1, H). Furthermore, liver tissues also were analyzed next for fibrosis status 
by assessing picrosirius red staining. The early primed MC mice liver showed significantly 
increased picrosirius red staining reactivity as compared with Lean mice (P < 0.001) (Fig. 
3.1, B and E). The above results thus suggested that an early MC exposure will induce 
early inflammation during the process of increased proinflammatory responses via MCP1, 
IL-1β and TNF-α. 
Early exposure to microcystin followed  by HFD will exacerbate liver injury  
We, as will other authors, have shown that toxins from the environmental exposure 
are acting as a second hit to intensify the progression of NAFLD from stage to advanced 
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one [6, 8]. We have also published that exogenous inhibitors of PP2A such as microcystin 
can worsen the pathophysiology  of NAFLD [87]. To investigate the role of early exposure 
to MC-LR in induction of liver injury in DIO model, we used a low, chronic dose of MC-
LR in mice immediately after weaning to induce liver injury, followed by feeding them 
HFD (DIO + MC). Results showed that DIO+MC group that shows the typical features of 
liver injury include increased infiltrating immune cells (inflammation), and hepatocytes 
ballooning when compared to with DIO control mice alone, lean mice exposed to MC, or 
lean mice (Fig. 4.2, A). Early exposure to microcystin also significantly elevated Serum 
ALT  level in DIO+MC mice as compared to lean, lean mice exposed to MC and DIO only 
mice (P<0.05) (Fig. 4.2, M) . Moreover, analysis of picrosirius staining in the early 
exposure to microcystin followed by HFD (DIO+MC) mice group showed increased 
reactivity as compared to lean, lean mice exposed to MC and DIO only mice (P<0.05) (Fig. 
4.2, B and F). CD68 immunoreactivity as well as mRNA levels is significantly increased 
in early exposure to microcystin followed by HFD mice group as compared to lean, lean 
mice exposed to MC and DIO only mice (P<0.05) (Fig. 4.2, C,G and J). This is indicative 
of Kupffer cell activation in early exposure to microcystin followed by HFD mice group 
as evidenced by significant increase in CD68.  Mice early exposed to MC also showed 
increase mRNA expression of proinflammatory cytokines TNF-α, IL-1β, and MCP1 as 
compared to the other groups (P<0.05) (Fig. 4.2, J). The above findings therefore indicated 
that proinflammatory responses via IL-1β , MCP1 and TNF-α are induced by early MC 
exposure in DIO mice. To study the effect of early microcystin exposure in NAFLD in 
stellate cell proliferation, immunohistochemistry, and mRNA expression of stellate cell 
activation marker α-SMA were studied. TGF-β also is studied similarly as α-SMA because 
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it has been shown in different researches to be key for fibrogenesis in liver injury outcomes 
[57, 127]. α-SMA as well as TGF-β  immunoreactivity and their mRNA  expression levels 
were significantly increased in the early exposure to microcystin followed by HFD 
(DIO+MC) mice groups when compared with DIO mice, the lean + MC mice group or lean 
(P < 0.001) (Fig. 3.2, D,E,H,I ,K and L).  
Early exposure to microcystin followed  by HFD will induce hepatic oxidative stress 
Oxidative stress is one of the most important pathogenic mechanisms associated 
with Liver injury [128, 129] . Evidence based research confirms that 3-Nitrotyrosine 
formation in vivo as well as in vitro occurs under various pathological conditions 
particularly in liver. 3-Nitrotyrosine (3-NT) is known to be a marker of peroxynitrite-
mediated oxidative damage in the diseased liver [130, 131]. Results showed that the 
immunoreactivity of 3-nitrotyrosine as analyzed by immunohistochemistry in early 
exposure to microcystin followed by HFD (DIO+MC) mice groups was significantly 
increased compared to DIO mice, the lean + MC mice group or lean  (Figure 4.3A and 
B)(P<0.05). This indicates that early exposure to microcystin has a clear role in the 
development of tyrosine radicals and tyrosine residue nitration in the high fat diet with 
early microcystin exposure group. 
Liver injury after early microcysin exposure is associated with inflammasome 
activation 
There are many studies indicating the role of NLRP3 inflammasome activation in 
different liver injuries as a major contributor to hepatocyte damage, activation of immune 
cells and hepatic inflammation [132-135] . Our group also has shown that microcystin can 
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mediate peroxynitrite species via NOX2 in inflammasome activation at intestinal 
inflammatory pathology [122]. To investigate whether early exposure to microcystin can 
result in inflammasome activation in the liver tissue, we measured mRNA expressions of 
the NLRP3 as well as ASC2  inflammasome sub-units. We also conducted colocalization 
events of both subunits for ASC2 and NLRP3 to demonstrate efficient assembly of the 
inflammasome complex.  Results showed that there was an increase in mRNA expression 
levels for NLRP3 as well as ASC2 inflammasome subunits in the early exposed to 
microcystin with HFD mice (DIO+MC) compared to with DIO control mice alone, lean 
mice exposed to MC, or lean mice (Figure 4.4,A,B,C, and D) (P<0.05). However, Caspase1 
mediated IL-1β as well as IL-18 release is completely associated with  NLRP3 
inflammasome activation in Kupffer cells [92, 136].  To investigate whether early exposure 
to microcystin can result in release  IL-1β and IL-18 as a pro-inflammatory cytokines 
depends on inflammasome activation, we measured mRNA expression that were assessed 
by qRT-PCR  and their immunoreactivity, which were assessed by immunofluorescence 
microscopy. Results showed that there was an increase in mRNA expression levels for IL-
1β and IL-18 genes in mice that have early exposure to microcysin followed with HFD 
(DIO+MC) as compared to with DIO control mice alone, lean mice exposed to MC, or lean 
mice (Figure 4.5, D and E) (P<0.05). Results also showed increased immunoreactivity of 
IL-1β and IL-18  in early exposed to MC with HFD (DIO + MC) mice groups as compared 
with  DIO control mice alone, lean mice exposed to MC, or lean mice (Figure 4.5, A,B and 
C) (P<0.05). Furthermore, to investigate the role NLRP3 inflammasome activation and 
subsequent liver injury outcomes going forward, we used NLRP3 gene-deleted mice 
(NLRP3 KO) early exposed to microcystin and fed them with a HFD. The 
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immunohistochemistry of 3NT, a marker of peroxynitrite-induced oxidative stress, as well 
as Kupffer cell activation marker CD68 were performed. Results showed that there was an 
significant increased immunoreactivity of 3NT in early exposed to MC with HFD (DIO + 
MC) mice when compared with DIO mice alone, whereas there was a significant reduction 
in NLRP3 KO mice groups that early exposed to MC (P = 0.013) (Fig.4.6, A and G). 
Results also showed increased immunoreactivity of CD68 in early exposed to MC with 
HFD (DIO + MC) mice groups as compared with DIO alone, whereas there was a 
significant decrease in NLRP3 KO mice groups that early exposed to MC (P < 0.001) 
(Fig.4.6, B and H). The mRNA expression of proinflammatory cytokines CD68, MCP1, 
and TNF-α showed a significant increase in early exposed to MC with HFD (DIO + MC) 
mice groups, whereas a decrease in NLRP3 KO mice groups that early exposed to MC was 
observed  (P < 0.001) (Fig. 4.6, M). Moreover, the immunoreactivity of a cytokine known 
for its role in fibrosis (TGFβ) using immunohistochemistry staining as well as the 
immunoreactivity of  stellate cell activation marker (α-SMA) using immunofluorescence 
staining were performed. Results showed that there was an significant increased 
immunoreactivity of TGF-β as well as α-SMA in early exposed to MC with HFD (DIO + 
MC) mice when compared with DIO mice alone, whereas there was a significant reduction 
in NLRP3 KO mice groups that early exposed to MC (P < 0.001) (Fig.4.6, C,D,I and J). 
Similarly, the mRNA expression of TGF-β and α-SMA genes showed a significant increase 
in early exposed to MC with HFD (DIO + MC) mice groups, whereas a decrease in NLRP3 
KO mice groups that early exposed to MC was observed  (P < 0.001) (Fig.4.6, N). Caspase1 
mediated IL-1β as well as IL-18 release also is evaluated. Results also showed increased 
immunoreactivity of IL-1β and IL-18  in early exposed to MC with HFD (DIO + MC) mice 
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groups as compared with DIO mice alone, whereas there was a significant reduction in 
NLRP3 KO mice groups that early exposed to MC (P < 0.001) (Fig.4.6, E,F,K and L). The 
mRNA expression of IL-1β and IL-18  genes showed a significant increase in early exposed 
to MC with HFD (DIO + MC) mice groups, whereas a decrease in NLRP3 KO mice groups 
that early exposed to MC was observed  (P < 0.001) (Fig.4.6, O). Together this data 
suggested that  early microcystin exposure activated Kupffer as well as stellate cells, 
increased inflammation, and were NLRP3 inflammasome assembly dependent. 
4.4 DISCUSSION 
The present study reports the role of early microcystin exposure in exacerbating 
livery injury outcomes. Moreover, this study suggests the role of assembling the NLRP3 
inflammasome complex in the progressing of liver injury. The findings reported in this 
study indicate that early MC-LR exposure induced increased inflammation, increased 
stellate cell activation, and early fibrosis starting. In addition, results showed that mice 
primed with subchronic doses of  microcystin for two weeks immediately after their 
weaning followed by a  high fat diet has increased serum ALT levels in comparison to the 
other groups. These are collectively  considered classical signs for early NAFLD link 
inflammation. Using these mice models that are highly translatable to humans  in 
generating the above data is suggesting that children and infants may be at risk of exposure 
to microcystin and subsequent hepatic injury, particularly if they are obese. These findings 
are connected to pediatric epidemiology data, as the NAFLD prevalence is increasing 
among children that are overweight in comparison to children who are not. This can have 
huge implications for them, causing NAFLD cases to advance to NASH. Our findings also 
assume relevance in clinical settings research using reports from Center for Disease 
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Control and Prevention, as it has been published that there are positive associations 
between obesity and progressions of chronic liver pathologies such as NASH. 
It has been shown by using the pharmacological inhibitor for NLRP3 activation in 
a mouse model of NASH, that liver injury including liver inflammation and fibrosis 
processes have been reduced [137]. The same findings have been shown by using knockout 
mouse models. There are also many triggers such as lipotoxic lipids, like free fatty acid, 
and diacylglycerols for hepatic NLRP3 inflammasome activation in NASH [138]. 
Moreover, the conceptual “two hit” or “multi hit” paradigm can be applied here by using 
environmental contaminants such as early microcystin exposure in DIO mice models for 
activation of NLRP3 inflammasome. In our study, in order to understand the role of early 
exposure to the microcystin in liver injury at diet induced obesity mice , we studied the 
activation of NLRP3 inflammasome using proteins as well as mRNA expression for genes. 
NLRP3 inflammasome, if activated, will result in activation of pro-caspase1 and pro-IL-
1β. That in turn will be converted to IL-1β, which is known to have a key role in NASH 
development within NAFLD spectrum  [133].  Our findings of increased NLRP3 and ASC2 
assembly using dual staining  for colocalization proved the process of inflammasome 
activation following priming with microcystin in DIO models. Subsequent to 
inflammasome activation there are increases in markers of Kupffer cells activation (CD68) 
as well as stellate cell activation (α-SMA) while at the same time there were observed 
decreases of all the above markers in NLRP3 KO mice. IL1B as well as IL18 are also 
shown to be increased in their expression in mice primed with microcystin in DIO models 
, while their level of expressions is attenuated in NLRP3 KO mice.  
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It has been shown by our group that oxidative stress mediated by peroxynitrite 
generation plays a central role in activating Kupffer cells during early steatohepatitic 
process in NASH [6]. We and others also have shown earlier that peroxynitrite generation 
in NAFLD creates a stable nitrated residue of tyrosine  called 3-nitrotyrosine (3NT) protein 
[6, 54]. This protein is established as a biomarker for oxidative stress in liver injuries [130, 
139]. Moreover, we published data that provided mechanistic cues in microcystin exposure 
that induced NASH pathology, wherein Kupffer cells could be the key cell site for the 
generation of NOX2-dependent ROS. In our study here, we found an increase at level of 
3-NT in mice primed with  microcystin in DIO models while also finding a decrease of this 
ROS marker in NLRP3 KO mice. This can give us a good evidence for the role of  NLRP3 
activation in ROS generation . 
Our results showed significant increase in expression levels of α-SMA and TGF-β 
in mice primed with microcystin in DIO models , while their level of expressions is reduced 
in NLRP3 KO mice. The fibrosis also was analyzed  by showing significant  increased 
morphometry  of picro sirius red in liver tissues slides  of mice primed with  microcystin 
in DIO models. This indicates that early exposure to microcystin can cause early fibrosis , 
which is considered a characteristic for early NAFLD-linked inflammation. 
In summary, our results clearly assumed that early exposure to microcystin causes 
liver injury outcomes in high fat diet-induced obesity and is dependent on NLRP3 
inflammasome activation. Drinking water or swimming in water sheds that have 
microcystin levels higher than EPA permissible limits particularly in childhood stage, 
might result in adult hepatic injury. Moreover, it can result in the development of metabolic 




Figure 4.1. Early priming with microcystin for two weeks  in juvenile mice liver induces 
liver injury . A: representative histological images of liver sections stained with 
hematoxylin-eosin (H&E), from lean mouse control and early primed with microcystin 
,MC (n = 3). B: representative histological images of the same groups of mice stained with 
picrosirius red (PicroS). C: Representative immunohistochemistry images of liver sections 
of the same groups of mice immunostained with CD68. Images were taken at ×20 
magnification.  D: Representative immunofluorescence images of liver sections of the 
same groups of mice immunostained with α-SMA (grean) counterstained with DAPI 
(blue). Images were taken at ×40 magnification.   Morphometric analysis of PicroS(E) 
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CD68 (F), and α-SMA (G) in lean mouse control and early primed with microcystin ,MC 
groups (n = 3/group). Morphometric analysis was expressed in percentage of positive 
immunoreactive area per regions of interest (ROIs) (3 ROIs/liver section). H:  Quantitative 
RT-PCR analysis of mRNA expression of CD68, TNF-α , MCP1, IL-1β, and α-SMA in 
lean, lean + MC livers. The mRNA expressions were normalized with 18s and presented 
















Figure 4.2. Early exposure to microcystin followed  by HFD will exacerbate liver injury . 
A: representative histological images of liver sections stained with hematoxylin-eosin 
(H&E), from lean mouse control, early exposed to microcystin (MC),DIO and DIO+MC 
(n = 3). B: representative histological images of the same groups of mice stained with 
picrosirius red (PicroS). Representative immunohistochemistry images of liver sections of 
the same groups of mice immunostained with CD68 (C), and TGF-β (D). Images were 
taken at ×20 magnification. E: Representative immunofluorescence images of liver 
sections of the same groups of mice immunostained with α-SMA (grean) counterstained 
with DAPI (blue). Images were taken at ×40 magnification.  Morphometric analysis of 
PicroS (F) CD68 (G),TGFβ (H) and α-SMA (G) in lean mouse control and exposed to 
microcystin (MC),DIO,DIO+MC groups (n = 3/group). Morphometric analysis was 
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3 
ROIs/liver section).  Quantitative RT-PCR analysis of mRNA expression of (J) 
CD68, TNF-α , MCP1, IL-1β, (K) TGF-β , and α-SMA (L) in lean, lean + MC, DIO, and 
DIO+MC livers. The mRNA expressions were normalized with 18s and presented as fold 
change of lean group. M: quantification of serum alanine aminotransferase (ALT) level 
and comparison between lean mouse control and exposed to microcystin 






Figure 4.3. Early exposure to microcystin followed  by HFD will induce hepatic oxidative 
stress. A: representative immunohistochemistry images of liver sections immunostained 
with 3-NT, from lean mouse control, early exposed to microcystin (MC),DIO and 
DIO+MC (n = 3). Images were taken at ×20 magnification.  B: Morphometric analysis of 
3-NT in lean mouse control and exposed to microcystin (MC),DIO,DIO+MC groups (n = 
3/group). Morphometric analysis was expressed in percentage of positive immunoreactive 
area per regions of interest (ROIs) (3 ROIs/liver section). *P < 0.05. Results were 





Figure 4.4. Early exposure to microcystin followed  by HFD induces NLRP3 
inflammasome activation. A: representative images of NLRP3 (red) and ASC2 (green) 
immunofluorescence counterstained with DAPI (blue) in in lean mouse control and 
exposed to microcystin (MC),DIO,DIO+MC groups (n = 3/group). Images were taken at 
×40 magnification. B:  morphometric analysis of NLRP3  and ASC2 colocalization 
expressed in percentage of positive colocalized immunoreactive area per region of interest 
(ROI) (3 ROIs/liver section, n = 3 each group).  Quantitative RT-PCR analysis of mRNA 
expression of NLRP3 (C) and ASC2 (D)  in lean, lean + MC, DIO, and DIO+MC livers. 
The mRNA expressions were normalized with 18s and presented as fold change of lean 





Figure 4.5. Early exposure to microcystin followed  by HFD releases IL-1β and IL-18. 
representative images of IL-1β (red) (A), and IL-18 (red)  (B) immunofluorescence 
counterstained with DAPI (blue) in in lean mouse control and exposed to microcystin 
(MC),DIO,DIO+MC groups (n = 3/group). Images were taken at ×40 magnification. 
Morphometric analysis of IL-1β  (C) and IL-18 (D)  in lean mouse control and exposed to 
microcystin (MC),DIO,DIO+MC groups (n = 3/group). Morphometric analysis was 
expressed in percentage of positive immunoreactive area per regions of interest (ROIs) (3 
ROIs/liver section). E: Quantitative RT-PCR analysis of mRNA expression of IL-1β  and 
IL-18 in lean, lean + MC, DIO, and DIO+MC livers. The mRNA expressions were 
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normalized with 18s and presented as fold change of lean group. *P < 0.05. Results were 













Figure 4.6. The activation of Kupffer cells, hepatic stellate cells, and an inflammatory surge 
in early microcystin (MC) exposure are mediated by NLRP3 inflammasome activation. 
Immunohistochemistry images of liver sections immunostained with 3-NT (A), CD68 (B), 
and TGF-β (C) from DIO, DIO+MC , and NLRP3 KO mice treated with MC (n = 3). 
Images were taken at 20X magnification. representative images of  α-SMA (Green) (D)  
,IL-1β (red) (E), and IL-18 (red)  (F) immunofluorescence counterstained with DAPI (blue) 
in DIO, DIO+MC , and NLRP3 KO mice treated with MC (n = 3/group). Images were 
taken at ×40 magnification. Morphometric analysis of  3-NT (G), CD68 (H), and TGF-β 
(I) IL-1β  (J) and IL-18 (K)  in DIO, DIO+MC , and NLRP3 KO mice treated with MC 
(n = 3/group). Morphometric analysis was expressed in percentage of positive 
immunoreactive area per regions of interest (ROIs) (3 ROIs/liver section). Quantitative 
RT-PCR analysis of mRNA expression of CD68, MCP1,TNF-α (L),TGF-β,α-SMA 
(M), IL-1β  and IL-18 (N) in DIO, DIO+MC , and NLRP3 KO mice treated with MC livers. 
The mRNA expressions were normalized with 18s and presented as fold change of DIO 






Obesity is a condition which arises due to the influence of multiple factors. 
According to Brehm and D’Alessio, some of these factors are external in the environmental 
predisposition while the others arise internally from the genetic structure [140]. There is a 
higher level of significance associated with the influence of  genetic factors in the nature 
and development of an individual. However, recent trends also indicate that other factors 
in an individual such as their social behavior, including education levels, food, and dietary 
patterns, as well as the level of physical activity, all influence the prevalence of obesity. 
Each of these factors influences the prevalence and development of obesity because they 
predispose an individual to conditions that influence and support there development and 
progress. Obesity as a genetic underlay also depends on these factors to manifest and 
actively develop because, in their absence, it is impossible to develop such a set of 
background attributes.  
Education levels influence an individual’s understanding of aspects such as diet and 
nutrition. Reduced levels of education mean that households lack the proper form of access 
to information and knowledge that would allow them to develop and sustain a healthy 
lifestyle [141]. The food market also defines the types of nutritional components which 
households access. The rise in the fast food market supports and leads to a higher level of 
obesity due to its level of sugars and fats. The market also makes it harder to access healthy 
alternatives. Further, eating patterns are a major factor in the prevalence of obesity [140]. 
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Practices such as binge eating, late eating, and attributes of frequency all have an influence 
on the presence and influence of obesity in an individual or a family setting. Ultimately, 
physical activity defines the level of exercise in an individual and influences how they use 
their food uptake.  
Jiang et al. (2016) indicate that obesity has a direct correlation with the presence 
and level of hypertension in an individual [142]. Essentially, obesity arises when an 
individual is unable to use up their extra food intake through energy expenditure. 
Therefore, the energy accumulates as fat and glycogen reserves in various parts of the body. 
An increase in weight due to the deposits and the specific areas where these deposits arise 
influence the circulatory system. Obesity arises due to associated conditions such as 
arteriosclerosis where fat and mineral components accumulate in blood vessels.  An extra 
amount of weight also puts additional pressure on the blood vessels to supply blood deeper 
into the tissues. There is a larger amount of energy expenditure that is necessary to support 
that higher level of activity in the tissues, which is the reason there is need for more flow 
of blood into the tissues.  
Further, there is a correlation between obesity and inflammatory, metabolic 
disorders. Some of these conditions arise due to genetic conditions or other factors 
surrounding an individual. A common example of these conditions is a non-alcoholic fatty 
liver disease which arises due to the abnormal deposition of fats in the liver [143]. The 
liver performs a role in detoxification and component breakdown through the process of 
oxidation. However, when there is an extra amount of deposition in the liver, there is a 
resultant effect of oxidative stress which leads to inflammation, injury, and dysfunction 
within the hepatic cells in the liver. The progression of non-alcoholic fatty liver disease 
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creates an adverse effect because most of its progress is asymptomatic. Therefore, the 
condition can arise and progress to a point where there is extensive hardening and scarring 
of tissues before it is possible to detect. Therefore, its effects are devastating to the affected 
subject.  
Previous studies have shown that pollutants from the environment behave in the 
liver as a "second/multiple hit" in order to augment NAFLD pathophysiology [6, 8]. For 
example, our group has shown that chronic low doses exposure to Bromo-dichloromethane 
(BDCM), which is known to be a prevalent by-product of water disinfection, can induce 
liver injury in preexisting NAFLD condition causing non-alcoholic steatohepatitis (NASH) 
via oxidative stress mediated by CYP2E1  in obese mice [6]. This idea has been translated 
into epidemiological study where using the U.S. Data from NHANES 1999–2006 as cross-
sectional study has revealed higher concentrations of the alanine aminotransferase (ALT), 
which is an enzyme that is used as a common marker of liver injury in people exposed to 
greater concentrations than average concentrations of trihalomethane brominated in their 
blood with prevalence odds ratios (ORs) equal to 1.35 times for its level (95% CI: 1.02, 
1.79) [144]. In both the United States and other countries, total trihalomethanes 
concentrations exceeding the benchmark exposure threshold as well as obesity prevalence 
continue to be reported [144]. 
In the present study, I examined the different basic molecular mechanisms of 
hepatic injury in NASH that is induced by microcystin exposure. Inhibition  of PP2A both 
via endogenous and exogenous routes can be a cause of livery injuries including in adult 
as well as juvenile age groups. An important public health issue is an increase in obesity 
prevalence as well as an increased prevalence of NAFLD among them. In NAFLD 
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progression to advanced NASH stage, the concept of two-hit and the multi-hit theory plays 
an important role, in which an environmental agent apart from obesity 
is a significant cause of liver injury. We found in our study that microcystin is activated 
Kupffer cells as well as hepatic stellate cells, that release the proinflammatory mediators 
involved in progression of NAFLD to NASH.  Different studies have shown that 
environmental toxicants exposure, which act as second hits, can regulate NOX2 activation 
in NAFLD condition. In our study we found in Kupffer cells that microcystin exposure will 
increase the activation of NOX2 and tyrosine nitration. This has been shown in vitro by 
visualizing the significant increase in GP91 phox-p47 phox colocalization events in 
Kupffer cells that have been exposed to leptin with MC as compared with other cell groups. 
In vivo also, we have been shown the significant increase in the colocalization events 
of GP91 phox-p47 phox  in NAFLD mice that have been exposed to microcystin as 
compared to other groups. Moreover, several publications have shown that microRNA 21 
(miR21) in NAFLD and NAFLD-associated kidney inflammation is upregulated there. If 
upregulated, miR21 also has been shown to regulate the NAFLD fibrogenesis via SMAD 
pathway. In our study, we have shown that microcystin can activate the miR21 in 
progressive NASH. We found in NAFLD mice that were exposed to microcystin that there 
is a significant increase in miR21 level of expression among them as compared to other 
groups. Interestingly, P47 phox KO mice that were exposed to microcystin showed a 
significant decline in miR21 expression level as compared to NAFLD mice that were 
exposed to microcystin. In addition, we found that miR21 KO as well as P47 phox KO 
mice that were exposed to microcystin showed a significant decrease in immunoreactivity 
of CD68, CD11b, and α-SMA. These are known biomarkers for  Kupffer cells as well as 
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hepatic stellate cells. This indicates that microcystin exposure can activate the NOX2-
induced miR21 which plays an important role in the activation of Kupffer cells and stellate 
cells. Mechanistically, immortalized Kupffer cells as well as stellate cells treated with 
pharmacological inhibitors such as apocynin ,nitrone spin trap DMPO, or phenyl boronic 
acid (FBA) with microcystin and leptin exposure showed a decrease in miR21 levels , 
activation of both Kupffer and stellate cell , and a decrease in inflammatory cytokines 
release. Moreover, using the same pharmacological inhibition in cells primed with leptin 
and co-exposed to microcystin showed attenuation in Gli 1, PTCG1, IHH , SHH gene 
expression, hallmarks for hedgehog signaling activation in NAFLD. 
We have also proved in our research that M1 phenotype increases in Kupffer cells 
via the same pathway by showing adaptation to an elongated morphology, activation of 
iNOS and release of nitric oxide. Further we showed that  blocking of the AKT pathway 
using AKT inhibtor decreased the ability of PP2A-inhibitor such as microcystin in 
induction of NOX2 activation and miR21 upregulation.   
In the juvenile mice study, we primed them with microcystin-LR (MC-LR) for two 
weeks after the end of weaning followed by high fat diet for four weeks . This study aimed 
to be translatable to what has been seen in clinical data. This is because it has been reported 
by American Academy of Pediatrics that there is a risk of early exposure to microcystin in 
infants as well as children. In our study, we have shown that early exposure to microcystin 
can increase proinflammatory cytokines and chemokines in diet induced obesity model as 
compared to other groups. Early exposure to microcystin can also increases the serum 
alanine aminotransferase (ALT) as compared to the other groups. Interestingly, we have 
shown the significant increase in the colocalization events of NLRP3-ASC2  in DIO mice 
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model that was primed with microcystin as compared to other groups. Moreover, in 
NLRP3 KO mice that were exposed to microcystin showed a significant decrease in the 
proinflammatory cytokines and chemokines levels as compared to DIO mice that were 
primed with microcystin. In summary, we can conclude that early exposure to microcystin 
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